{"id":237997,"date":"2024-05-20T16:11:00","date_gmt":"2024-05-20T08:11:00","guid":{"rendered":"https:\/\/pingtungtimes.com.tw\/?p=237997"},"modified":"2024-05-20T16:11:00","modified_gmt":"2024-05-20T08:11:00","slug":"%e9%bc%8e%e5%84%aa%e6%a8%82%ef%bc%88%e8%88%92%e5%b7%b4%e5%9d%a6%e9%88%89-%e5%ba%a6%e6%b4%9b%e5%b7%b4%e5%9d%a6%e9%88%89%ef%bc%89%e7%8d%b2%e4%b8%ad%e5%9c%8b%e5%9c%8b%e5%ae%b6%e8%97%a5%e7%9b%a3","status":"publish","type":"post","link":"https:\/\/pingtungtimes.com.tw\/?p=237997","title":{"rendered":"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02"},"content":{"rendered":"<div>\n<ul type=\"disc\">\n<li><b><i>\u6839\u64da\u4e16\u885b\u7d44\u7e54\uff0c\u8010\u85e5\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u5168\u7403\u5065\u5eb7\u7684\u5a01\u8105\u65e5\u76ca\u7dca\u8feb\uff0c\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4<\/i><\/b><\/li>\n<li><b><i>\u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u7684\u6279\u51c6\u662f\u57fa\u65bc\u5168\u9762\u7684\u81e8\u5e8a\u6578\u64da\uff0c\u8b49\u660eSUL-DUR\u5c0d\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u83cc\u682a\u5177\u6709\u826f\u597d\u7684\u6d3b\u6027<\/i><\/b><\/li>\n<li><b><i>\u4e2d\u570b\u7d04\u670930\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0474%\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5<\/i><\/b><\/li>\n<\/ul>\n<p>\u4e0a\u6d77\u548c\u99ac\u85a9\u8af8\u585e\u5dde\u528d\u6a4b2024\u5e745\u670820\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u518d\u9f0e\u91ab\u85e5\u6709\u9650\u516c\u53f8\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aZLAB\uff1b\u9999\u6e2f\u806f\u4ea4\u6240\u80a1\u4efd\u4ee3\u865f\uff1a9688\uff09\u548cInnoviva Specialty Therapeutics\u4eca\u65e5\u5ba3\u4f48\uff0c\u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u5df2\u7d93\u6279\u51c6\u4e86\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0cSUL-DUR\uff09\u7684\u65b0\u85e5\u4e0a\u5e02\u7533\u8acb\uff0c\u7528\u65bc\u6cbb\u764218\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u6240\u81f4\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\uff09\u3001\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08VABP\uff09\u3002\u4e16\u754c\u885b\u751f\u7d44\u7e54\u8a8d\u70ba\u4e0d\u52d5\u687f\u83cc\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4\u4e4b\u4e00<sup>[1]<\/sup>\u3002<\/p>\n<p>\u518d\u9f0e\u91ab\u85e5\u7e3d\u88c1\uff0c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u3001\u81ea\u8eab\u514d\u75ab\u53ca\u611f\u67d3\u6027\u75be\u75c5\u9818\u57df\u5168\u7403\u958b\u767c\u8ca0\u8cac\u4eba\u4efb\u6d77\u777f\u535a\u58eb\u8868\u793a\uff1a\u300c \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7372\u5f97\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u7684\u6279\u51c6\uff0c\u51f8\u986f\u4e86\u518d\u9f0e\u81f4\u529b\u65bc\u958b\u767c\u548c\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u4ee5\u6eff\u8db3\u4e2d\u570b\u548c\u5168\u7403\u60a3\u8005\u7684\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u3002\u5c0d\u65bc\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5c0d\u516c\u773e\u7684\u5a01\u8105\uff0c\u6211\u5011\u4e9f\u9700\u63a1\u53d6\u884c\u52d5\uff0c\u56e0\u70ba\u60a3\u8005\u7684\u6cbb\u7642\u9078\u64c7\u6709\u9650\uff0c\u6b7b\u4ea1\u7387\u9ad8\u3002\u6211\u5011\u5805\u4fe1\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7372\u6279\u4ee3\u8868\u4e86\u6211\u5011\u5728\u60a3\u8005\u5b58\u5728\u5de8\u5927\u9700\u6c42\u7684\u9818\u57df\u53c8\u5411\u524d\u9081\u9032\u4e86\u4e00\u6b65\u3002\u300d\u00a0<\/p>\n<p>\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u4e2d\u570b\u7372\u6279\u662f\u57fa\u65bcATTACK\u7814\u7a76\uff08NCT03894046\uff09\u7684\u7a4d\u6975\u7d50\u679c\uff0c\u8a72\u7814\u7a76\u662f\u4e00\u9805\u5168\u74033\u671f\u8a3b\u518a\u6027\u7814\u7a76\uff0c\u8a55\u4f30\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209v.s\u591a\u7c98\u83cc\u7d20E\u7528\u65bc\u6cbb\u7642\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u5728\u8a72\u7814\u7a76\u4e2d\uff0c\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u7814\u7a76\u4e3b\u8981\u7d42\u9ede\uff0c\u5373\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u768428\u5929\u5168\u56e0\u6b7b\u4ea1\u7387\u65b9\u9762\uff0c\u8207\u591a\u7c98\u83cc\u7d20E\u76f8\u6bd4\u5177\u6709\u7d71\u8a08\u5b78\u4e0a\u7684\u975e\u52a3\u6548\u6027\uff0c\u4e26\u4e14\u5728\u81e8\u5e8a\u6cbb\u7652\u7387\u65b9\u9762\u6709\u986f\u8457\u63d0\u5347\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u4e26\u5728\u6574\u500b\u81e8\u5e8a\u7814\u7a76\u9805\u76ee\u4e2d\u5747\u8868\u73fe\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u7279\u5fb5\u3002\u518d\u9f0e\u91ab\u85e5\u53c3\u8207\u4e86ATTACK\u5168\u7403\u7814\u7a76\uff0c\u5728\u4e2d\u570b\u62db\u52df\u60a3\u8005\u3002\u4e2d\u570b\u60a3\u8005\u968a\u5217\u6578\u64da\u8b49\u5be6\u4e86\u5168\u7403\u7814\u7a76\u4e2d\u95dc\u65bc\u6b7b\u4ea1\u7387\u548c\u81e8\u5e8a\u61c9\u7b54\u6539\u5584\u7684\u7d50\u679c\u3002<\/p>\n<p>2023\u5e745\u6708\uff0cInnoviva Specialty Therapeutics\u5ba3\u4f48\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u6279\u51c6\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u7684\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u7684\u6210\u4eba\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff0c\u9019\u662fFDA\u6279\u51c6\u7684\u9996\u6b3e\u9776\u5411\u91dd\u5c0d\u8a72\u75c5\u539f\u9ad4\u7684\u7642\u6cd5\u3002<\/p>\n<p><b>\u95dc\u65bc\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09<\/b><\/p>\n<p>\u975c\u8108\u8f38\u6ce8\u578b\u7d44\u5408\u85e5\u7269\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7531Entasis Therapeutics\uff08Innoviva Specialty Therapeutics\u7684\u4e00\u5bb6\u95dc\u806f\u516c\u53f8\uff09\u958b\u767c\uff0c\u662f\u7531\u8212\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u985e\u6297\u751f\u7d20\uff09\u548c\u5ea6\u6d1b\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u9176\u6291\u5236\u5291\uff09\u7d44\u5408\u800c\u6210\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5167\u5730\u7372\u6279\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u768418\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7684\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\/VABP\uff09\u3002\u518d\u9f0e\u91ab\u85e5\u64c1\u6709\u5728\u5927\u4e2d\u83ef\u5340\uff08\u4e2d\u570b\u5167\u5730\u3001\u9999\u6e2f\u3001\u53f0\u7063\u5730\u5340\u548c\u6fb3\u9580\u7684\u5408\u7a31\uff09\u3001\u97d3\u570b\u3001\u8d8a\u5357\u3001\u6cf0\u570b\u3001\u67ec\u57d4\u5be8\u3001\u8001\u64be\u3001\u99ac\u4f86\u897f\u4e9e\u3001\u5370\u5ea6\u5c3c\u897f\u4e9e\u3001\u83f2\u5f8b\u8cd3\u3001\u65b0\u52a0\u5761\u3001\u6fb3\u5927\u5229\u4e9e\u3001\u65b0\u897f\u862d\u548c\u65e5\u672c\u958b\u767c\u548c\u5546\u696d\u5316\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7368\u4f54\u8a31\u53ef\u3002<\/p>\n<p><b>\u95dc\u65bc\u4e0d\u52d5\u687f\u83cc<\/b><\/p>\n<p>\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\uff08\u4e0d\u52d5\u687f\u83cc\uff09\u662f\u9769\u862d\u6c0f\u9670\u6027\u3001\u4eba\u985e\u6a5f\u6703\u6027\u611f\u67d3\u75c5\u539f\u9ad4\uff0c\u4e3b\u8981\u611f\u67d3\u91cd\u75c7\u60a3\u8005\uff0c\u901a\u5e38\u6703\u5c0e\u81f4\u56b4\u91cd\u7684\u80ba\u708e\u548c\u8840\u6d41\u611f\u67d3<sup>[1]<\/sup>\u3002\u5b83\u5011\u9084\u53ef\u4ee5\u611f\u67d3\u5176\u4ed6\u8eab\u9ad4\u90e8\u4f4d\uff0c\u4f8b\u5982\u6ccc\u5c3f\u9053\u548c\u76ae\u819a\u3002\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u88ab\u8a8d\u70ba\u662f\u4e00\u7a2e\u5168\u7403\u6027\u7684\u516c\u5171\u885b\u751f\u5a01\u8105\uff0c\u90e8\u5206\u539f\u56e0\u662f\u5176\u80fd\u5920\u7372\u5f97\u591a\u91cd\u8010\u85e5\u6027\u3002\u4e0d\u52d5\u687f\u83cc\u5c0d\u9752\u9ef4\u7d20\u985e\u85e5\u7269\u5177\u6709\u8010\u85e5\u6027\uff0c\u4e26\u4e14\u9084\u7372\u5f97\u4e86\u5c0d\u5e7e\u4e4e\u6240\u6709\u7528\u65bc\u6cbb\u7642\u9769\u862d\u6c0f\u9670\u6027\u83cc\u7684\u6297\u751f\u7d20\u7684\u8010\u85e5\u57fa\u56e0\uff0c\u5305\u62ec\u6c1f\u594e\u8afe\u916e\u985e\u85e5\u7269\u3001\u6c28\u57fa\u7cd6\u7518\u985e\u85e5\u7269\u3001\u982d\u5b62\u83cc\u7d20\u985e\u85e5\u7269\u548c\u78b3\u9752\u9709\u70ef\u985e\u85e5\u7269\u3002<\/p>\n<p>\u7f8e\u570b\u75be\u75c5\u63a7\u5236\u8207\u9810\u9632\u4e2d\u5fc3\uff08CDC\uff09\u5df2\u5c07\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u5fae\u751f\u7269\u5217\u70ba\u7dca\u8feb\u5a01\u8105<sup>[2]<\/sup>\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u662f2019\u5e74\u8207\u8010\u85e5\u6027\u76f8\u95dc\u7684\u6b7b\u4ea1\u7684\u516d\u5927\u4e3b\u8981\u75c5\u539f\u9ad4\u4e4b\u4e00<sup>[3]<\/sup>\u3002\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u88ab\u4e16\u754c\u885b\u751f\u7d44\u7e54\u5217\u70ba\u512a\u5148\u7684\u75c5\u539f\u9ad4<sup>[4]<\/sup>\u3002<\/p>\n<p>\u5728\u7f8e\u570b\uff0c\u6bcf\u5e74\u9810\u8a08\u7d04\u670940,000\u5230800,000\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0440%\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc<sup>[5],[6]<\/sup>\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u6bcf\u5e74\u7d04\u6709100\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d04\u4e09\u5206\u4e4b\u4e8c\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc<sup><span id=\"spanHghlta1e6\">[5]<\/span><\/sup>\u3002\u5168\u7403\u6bcf\u5e74\u6709\u8d85\u904e300,000\u4f8b\u6b7b\u4ea1\u8207\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u6709\u95dc<sup>[7]<\/sup>\u3002<\/p>\n<p><b>\u95dc\u65bc\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5728\u4e2d\u570b<\/b><\/p>\n<p>\u6839\u64daCARSS\uff08\u5168\u570b\u7d30\u83cc\u8010\u85e5\u76e3\u6e2c\u7db2\uff092022\u5e74\u5e74\u5ea6\u5831\u544a\uff0c\u4e2d\u570b\u5167\u5730\u7d04\u670930\u842c\u4f8b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5831\u544a\u3002\u6839\u64da\u6700\u65b0\u7684CHINET\u5831\u544a\uff0c\u4e2d\u570b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u6297\u751f\u7d20\u7684\u8010\u85e5\u7387\u5df2\u5347\u81f3\u7d0474%\u3002\u5728\u4e2d\u570b\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u4e5f\u662f\u5c0e\u81f4\u91ab\u9662\u7372\u5f97\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u80ba\u708e\u7684\u5e38\u898b\u75c5\u539f\u9ad4<sup>[8]<\/sup>\u3002\u5728\u63d0\u4f9b\u73fe\u6709\u6cbb\u7642\u7684\u60c5\u6cc1\u4e0b\uff0c\u5176\u5728\u4e2d\u570b\u548c\u6771\u4e9e\u7684\u6b7b\u4ea1\u7387\u5206\u5225\u7d04\u70ba38%\u548c43%<sup>[9]<\/sup>\u3002<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tbody>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[1] Tala, B., Jad, A., Claude, A., Jihad, I., Chantal, L., Rakan, N.,&amp; Eid, A. (2017). Risk Factors, Clinical Presentation, and Outcome of\u202fAcinetobacter<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[2] Centers for Disease Control and Prevention, &#8220;Carbapenem-resistant\u202fAcinetobacter baumannii\u202f(CRAB): An urgent public health threat in\u202fUnited States\u202fhealthcare facilities,&#8221;\u202fAugust 2021:\u202fhttps:\/\/arpsp.cdc.gov\/story\/cra-urgent-public-health-threat<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[3] Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[4] World Health Organization, &#8220;WHO publishes list of bacteria for which new antibiotics are urgently needed,&#8221; February 27, 2017: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[5] Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discov. 2013 Dec;12(12):963. doi: 10.1038\/nrd3957-c1. Epub 2013 Nov 15.<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[6] Centers for Disease Control and Prevention. Antibiotic Resistance &amp; Patient Safety Portal. &#8220;Carbapenem-resistant Acinetobacter,&#8221; May 2023: https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/carbapenem-resistant-acinetobacter<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[7] Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655. Supplementary Material. Supplementary appendix.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[8] China Diagnosis and Treatment Guideline for hospital-acquired pneumonia and ventilator-associated pneumonia, 2018;\u00a0<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\"><span class=\"prnews_span\">[9] Chung DR, et al; Asian Network for Surveillance of Resistant Pathogens Study Group. Am J Respir Crit Care Med 2011; Du, et al. American Journal of Infection Control 00 (2019).<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u6839\u64da\u4e16\u885b\u7d44\u7e54\uff0c\u8010\u85e5\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc&#8230;<\/p>\n","protected":false},"author":16,"featured_media":199219,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[40567],"tags":[],"class_list":["post-237997","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-40567"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831<\/title>\n<meta name=\"description\" content=\"\u6839\u64da\u4e16\u885b\u7d44\u7e54\uff0c\u8010\u85e5\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u5168\u7403\u5065\u5eb7\u7684\u5a01\u8105\u65e5\u76ca\u7dca\u8feb\uff0c\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4  \u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u7684\u6279\u51c6\u662f\u57fa\u65bc\u5168\u9762\u7684\u81e8\u5e8a\u6578\u64da\uff0c\u8b49\u660eSUL-DUR\u5c0d\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u83cc\u682a\u5177\u6709\u826f\u597d\u7684\u6d3b\u6027  \u4e2d\u570b\u7d04\u670930\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0474%\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5  \u4e0a\u6d77\u548c\u99ac\u85a9\u8af8\u585e\u5dde\u528d\u6a4b2024\u5e745\u670820\u65e5 \/\u7f8e\u901a\u793e\/ -- \u518d\u9f0e\u91ab\u85e5\u6709\u9650\u516c\u53f8\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aZLAB\uff1b\u9999\u6e2f\u806f\u4ea4\u6240\u80a1\u4efd\u4ee3\u865f\uff1a9688\uff09\u548cInnoviva Specialty Therapeutics\u4eca\u65e5\u5ba3\u4f48\uff0c\u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u5df2\u7d93\u6279\u51c6\u4e86\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0cSUL-DUR\uff09\u7684\u65b0\u85e5\u4e0a\u5e02\u7533\u8acb\uff0c\u7528\u65bc\u6cbb\u764218\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u6240\u81f4\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\uff09\u3001\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08VABP\uff09\u3002\u4e16\u754c\u885b\u751f\u7d44\u7e54\u8a8d\u70ba\u4e0d\u52d5\u687f\u83cc\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002 \u518d\u9f0e\u91ab\u85e5\u7e3d\u88c1\uff0c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u3001\u81ea\u8eab\u514d\u75ab\u53ca\u611f\u67d3\u6027\u75be\u75c5\u9818\u57df\u5168\u7403\u958b\u767c\u8ca0\u8cac\u4eba\u4efb\u6d77\u777f\u535a\u58eb\u8868\u793a\uff1a\u300c \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7372\u5f97\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u7684\u6279\u51c6\uff0c\u51f8\u986f\u4e86\u518d\u9f0e\u81f4\u529b\u65bc\u958b\u767c\u548c\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u4ee5\u6eff\u8db3\u4e2d\u570b\u548c\u5168\u7403\u60a3\u8005\u7684\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u3002\u5c0d\u65bc\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5c0d\u516c\u773e\u7684\u5a01\u8105\uff0c\u6211\u5011\u4e9f\u9700\u63a1\u53d6\u884c\u52d5\uff0c\u56e0\u70ba\u60a3\u8005\u7684\u6cbb\u7642\u9078\u64c7\u6709\u9650\uff0c\u6b7b\u4ea1\u7387\u9ad8\u3002\u6211\u5011\u5805\u4fe1\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7372\u6279\u4ee3\u8868\u4e86\u6211\u5011\u5728\u60a3\u8005\u5b58\u5728\u5de8\u5927\u9700\u6c42\u7684\u9818\u57df\u53c8\u5411\u524d\u9081\u9032\u4e86\u4e00\u6b65\u3002\u300d\u00a0 \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u4e2d\u570b\u7372\u6279\u662f\u57fa\u65bcATTACK\u7814\u7a76\uff08NCT03894046\uff09\u7684\u7a4d\u6975\u7d50\u679c\uff0c\u8a72\u7814\u7a76\u662f\u4e00\u9805\u5168\u74033\u671f\u8a3b\u518a\u6027\u7814\u7a76\uff0c\u8a55\u4f30\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209v.s\u591a\u7c98\u83cc\u7d20E\u7528\u65bc\u6cbb\u7642\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u5728\u8a72\u7814\u7a76\u4e2d\uff0c\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u7814\u7a76\u4e3b\u8981\u7d42\u9ede\uff0c\u5373\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u768428\u5929\u5168\u56e0\u6b7b\u4ea1\u7387\u65b9\u9762\uff0c\u8207\u591a\u7c98\u83cc\u7d20E\u76f8\u6bd4\u5177\u6709\u7d71\u8a08\u5b78\u4e0a\u7684\u975e\u52a3\u6548\u6027\uff0c\u4e26\u4e14\u5728\u81e8\u5e8a\u6cbb\u7652\u7387\u65b9\u9762\u6709\u986f\u8457\u63d0\u5347\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u4e26\u5728\u6574\u500b\u81e8\u5e8a\u7814\u7a76\u9805\u76ee\u4e2d\u5747\u8868\u73fe\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u7279\u5fb5\u3002\u518d\u9f0e\u91ab\u85e5\u53c3\u8207\u4e86ATTACK\u5168\u7403\u7814\u7a76\uff0c\u5728\u4e2d\u570b\u62db\u52df\u60a3\u8005\u3002\u4e2d\u570b\u60a3\u8005\u968a\u5217\u6578\u64da\u8b49\u5be6\u4e86\u5168\u7403\u7814\u7a76\u4e2d\u95dc\u65bc\u6b7b\u4ea1\u7387\u548c\u81e8\u5e8a\u61c9\u7b54\u6539\u5584\u7684\u7d50\u679c\u3002 2023\u5e745\u6708\uff0cInnoviva Specialty Therapeutics\u5ba3\u4f48\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u6279\u51c6\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u7684\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u7684\u6210\u4eba\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff0c\u9019\u662fFDA\u6279\u51c6\u7684\u9996\u6b3e\u9776\u5411\u91dd\u5c0d\u8a72\u75c5\u539f\u9ad4\u7684\u7642\u6cd5\u3002 \u95dc\u65bc\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09 \u975c\u8108\u8f38\u6ce8\u578b\u7d44\u5408\u85e5\u7269\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7531Entasis Therapeutics\uff08Innoviva Specialty Therapeutics\u7684\u4e00\u5bb6\u95dc\u806f\u516c\u53f8\uff09\u958b\u767c\uff0c\u662f\u7531\u8212\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u985e\u6297\u751f\u7d20\uff09\u548c\u5ea6\u6d1b\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u9176\u6291\u5236\u5291\uff09\u7d44\u5408\u800c\u6210\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5167\u5730\u7372\u6279\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u768418\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7684\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\/VABP\uff09\u3002\u518d\u9f0e\u91ab\u85e5\u64c1\u6709\u5728\u5927\u4e2d\u83ef\u5340\uff08\u4e2d\u570b\u5167\u5730\u3001\u9999\u6e2f\u3001\u53f0\u7063\u5730\u5340\u548c\u6fb3\u9580\u7684\u5408\u7a31\uff09\u3001\u97d3\u570b\u3001\u8d8a\u5357\u3001\u6cf0\u570b\u3001\u67ec\u57d4\u5be8\u3001\u8001\u64be\u3001\u99ac\u4f86\u897f\u4e9e\u3001\u5370\u5ea6\u5c3c\u897f\u4e9e\u3001\u83f2\u5f8b\u8cd3\u3001\u65b0\u52a0\u5761\u3001\u6fb3\u5927\u5229\u4e9e\u3001\u65b0\u897f\u862d\u548c\u65e5\u672c\u958b\u767c\u548c\u5546\u696d\u5316\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7368\u4f54\u8a31\u53ef\u3002 \u95dc\u65bc\u4e0d\u52d5\u687f\u83cc \u9b91\u66fc\u4e0d\u52d5\u687f\u83cc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\uff08\u4e0d\u52d5\u687f\u83cc\uff09\u662f\u9769\u862d\u6c0f\u9670\u6027\u3001\u4eba\u985e\u6a5f\u6703\u6027\u611f\u67d3\u75c5\u539f\u9ad4\uff0c\u4e3b\u8981\u611f\u67d3\u91cd\u75c7\u60a3\u8005\uff0c\u901a\u5e38\u6703\u5c0e\u81f4\u56b4\u91cd\u7684\u80ba\u708e\u548c\u8840\u6d41\u611f\u67d3\u3002\u5b83\u5011\u9084\u53ef\u4ee5\u611f\u67d3\u5176\u4ed6\u8eab\u9ad4\u90e8\u4f4d\uff0c\u4f8b\u5982\u6ccc\u5c3f\u9053\u548c\u76ae\u819a\u3002\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u88ab\u8a8d\u70ba\u662f\u4e00\u7a2e\u5168\u7403\u6027\u7684\u516c\u5171\u885b\u751f\u5a01\u8105\uff0c\u90e8\u5206\u539f\u56e0\u662f\u5176\u80fd\u5920\u7372\u5f97\u591a\u91cd\u8010\u85e5\u6027\u3002\u4e0d\u52d5\u687f\u83cc\u5c0d\u9752\u9ef4\u7d20\u985e\u85e5\u7269\u5177\u6709\u8010\u85e5\u6027\uff0c\u4e26\u4e14\u9084\u7372\u5f97\u4e86\u5c0d\u5e7e\u4e4e\u6240\u6709\u7528\u65bc\u6cbb\u7642\u9769\u862d\u6c0f\u9670\u6027\u83cc\u7684\u6297\u751f\u7d20\u7684\u8010\u85e5\u57fa\u56e0\uff0c\u5305\u62ec\u6c1f\u594e\u8afe\u916e\u985e\u85e5\u7269\u3001\u6c28\u57fa\u7cd6\u7518\u985e\u85e5\u7269\u3001\u982d\u5b62\u83cc\u7d20\u985e\u85e5\u7269\u548c\u78b3\u9752\u9709\u70ef\u985e\u85e5\u7269\u3002 \u7f8e\u570b\u75be\u75c5\u63a7\u5236\u8207\u9810\u9632\u4e2d\u5fc3\uff08CDC\uff09\u5df2\u5c07\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u5fae\u751f\u7269\u5217\u70ba\u7dca\u8feb\u5a01\u8105\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u662f2019\u5e74\u8207\u8010\u85e5\u6027\u76f8\u95dc\u7684\u6b7b\u4ea1\u7684\u516d\u5927\u4e3b\u8981\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u88ab\u4e16\u754c\u885b\u751f\u7d44\u7e54\u5217\u70ba\u512a\u5148\u7684\u75c5\u539f\u9ad4\u3002 \u5728\u7f8e\u570b\uff0c\u6bcf\u5e74\u9810\u8a08\u7d04\u670940,000\u5230800,000\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0440%\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc,\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u6bcf\u5e74\u7d04\u6709100\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d04\u4e09\u5206\u4e4b\u4e8c\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u3002\u5168\u7403\u6bcf\u5e74\u6709\u8d85\u904e300,000\u4f8b\u6b7b\u4ea1\u8207\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u6709\u95dc\u3002 \u95dc\u65bc\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5728\u4e2d\u570b \u6839\u64daCARSS\uff08\u5168\u570b\u7d30\u83cc\u8010\u85e5\u76e3\u6e2c\u7db2\uff092022\u5e74\u5e74\u5ea6\u5831\u544a\uff0c\u4e2d\u570b\u5167\u5730\u7d04\u670930\u842c\u4f8b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5831\u544a\u3002\u6839\u64da\u6700\u65b0\u7684CHINET\u5831\u544a\uff0c\u4e2d\u570b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u6297\u751f\u7d20\u7684\u8010\u85e5\u7387\u5df2\u5347\u81f3\u7d0474%\u3002\u5728\u4e2d\u570b\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u4e5f\u662f\u5c0e\u81f4\u91ab\u9662\u7372\u5f97\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u80ba\u708e\u7684\u5e38\u898b\u75c5\u539f\u9ad4\u3002\u5728\u63d0\u4f9b\u73fe\u6709\u6cbb\u7642\u7684\u60c5\u6cc1\u4e0b\uff0c\u5176\u5728\u4e2d\u570b\u548c\u6771\u4e9e\u7684\u6b7b\u4ea1\u7387\u5206\u5225\u7d04\u70ba38%\u548c43%\u3002           Tala, B., Jad, A., Claude, A., Jihad, I., Chantal, L., Rakan, N.,&amp; Eid, A. (2017). Risk Factors, Clinical Presentation, and Outcome of\u202fAcinetobacter         Centers for Disease Control and Prevention, &quot;Carbapenem-resistant\u202fAcinetobacter baumannii\u202f(CRAB): An urgent public health threat in\u202fUnited States\u202fhealthcare facilities,&quot;\u202fAugust 2021:\u202fhttps:\/\/arpsp.cdc.gov\/story\/cra-urgent-public-health-threat         Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext         World Health Organization, &quot;WHO publishes list of bacteria for which new antibiotics are urgently needed,&quot; February 27, 2017: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed         Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discov. 2013 Dec;12(12):963. doi: 10.1038\/nrd3957-c1. Epub 2013 Nov 15.         Centers for Disease Control and Prevention. Antibiotic Resistance &amp; Patient Safety Portal. &quot;Carbapenem-resistant Acinetobacter,&quot; May 2023: https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/carbapenem-resistant-acinetobacter         Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655. Supplementary Material. Supplementary appendix.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext         China Diagnosis and Treatment Guideline for hospital-acquired pneumonia and ventilator-associated pneumonia, 2018;\u00a0         Chung DR, et al; Asian Network for Surveillance of Resistant Pathogens Study Group. Am J Respir Crit Care Med 2011; Du, et al. American Journal of Infection Control 00 (2019).         \u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pingtungtimes.com.tw\/?p=237997\" \/>\n<meta property=\"og:locale\" content=\"zh_TW\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"og:description\" content=\"\u6839\u64da\u4e16\u885b\u7d44\u7e54\uff0c\u8010\u85e5\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u5168\u7403\u5065\u5eb7\u7684\u5a01\u8105\u65e5\u76ca\u7dca\u8feb\uff0c\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4  \u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u7684\u6279\u51c6\u662f\u57fa\u65bc\u5168\u9762\u7684\u81e8\u5e8a\u6578\u64da\uff0c\u8b49\u660eSUL-DUR\u5c0d\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u83cc\u682a\u5177\u6709\u826f\u597d\u7684\u6d3b\u6027  \u4e2d\u570b\u7d04\u670930\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0474%\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5  \u4e0a\u6d77\u548c\u99ac\u85a9\u8af8\u585e\u5dde\u528d\u6a4b2024\u5e745\u670820\u65e5 \/\u7f8e\u901a\u793e\/ -- \u518d\u9f0e\u91ab\u85e5\u6709\u9650\u516c\u53f8\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aZLAB\uff1b\u9999\u6e2f\u806f\u4ea4\u6240\u80a1\u4efd\u4ee3\u865f\uff1a9688\uff09\u548cInnoviva Specialty Therapeutics\u4eca\u65e5\u5ba3\u4f48\uff0c\u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u5df2\u7d93\u6279\u51c6\u4e86\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0cSUL-DUR\uff09\u7684\u65b0\u85e5\u4e0a\u5e02\u7533\u8acb\uff0c\u7528\u65bc\u6cbb\u764218\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u6240\u81f4\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\uff09\u3001\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08VABP\uff09\u3002\u4e16\u754c\u885b\u751f\u7d44\u7e54\u8a8d\u70ba\u4e0d\u52d5\u687f\u83cc\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002 \u518d\u9f0e\u91ab\u85e5\u7e3d\u88c1\uff0c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u3001\u81ea\u8eab\u514d\u75ab\u53ca\u611f\u67d3\u6027\u75be\u75c5\u9818\u57df\u5168\u7403\u958b\u767c\u8ca0\u8cac\u4eba\u4efb\u6d77\u777f\u535a\u58eb\u8868\u793a\uff1a\u300c \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7372\u5f97\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u7684\u6279\u51c6\uff0c\u51f8\u986f\u4e86\u518d\u9f0e\u81f4\u529b\u65bc\u958b\u767c\u548c\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u4ee5\u6eff\u8db3\u4e2d\u570b\u548c\u5168\u7403\u60a3\u8005\u7684\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u3002\u5c0d\u65bc\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5c0d\u516c\u773e\u7684\u5a01\u8105\uff0c\u6211\u5011\u4e9f\u9700\u63a1\u53d6\u884c\u52d5\uff0c\u56e0\u70ba\u60a3\u8005\u7684\u6cbb\u7642\u9078\u64c7\u6709\u9650\uff0c\u6b7b\u4ea1\u7387\u9ad8\u3002\u6211\u5011\u5805\u4fe1\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7372\u6279\u4ee3\u8868\u4e86\u6211\u5011\u5728\u60a3\u8005\u5b58\u5728\u5de8\u5927\u9700\u6c42\u7684\u9818\u57df\u53c8\u5411\u524d\u9081\u9032\u4e86\u4e00\u6b65\u3002\u300d\u00a0 \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u4e2d\u570b\u7372\u6279\u662f\u57fa\u65bcATTACK\u7814\u7a76\uff08NCT03894046\uff09\u7684\u7a4d\u6975\u7d50\u679c\uff0c\u8a72\u7814\u7a76\u662f\u4e00\u9805\u5168\u74033\u671f\u8a3b\u518a\u6027\u7814\u7a76\uff0c\u8a55\u4f30\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209v.s\u591a\u7c98\u83cc\u7d20E\u7528\u65bc\u6cbb\u7642\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u5728\u8a72\u7814\u7a76\u4e2d\uff0c\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u7814\u7a76\u4e3b\u8981\u7d42\u9ede\uff0c\u5373\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u768428\u5929\u5168\u56e0\u6b7b\u4ea1\u7387\u65b9\u9762\uff0c\u8207\u591a\u7c98\u83cc\u7d20E\u76f8\u6bd4\u5177\u6709\u7d71\u8a08\u5b78\u4e0a\u7684\u975e\u52a3\u6548\u6027\uff0c\u4e26\u4e14\u5728\u81e8\u5e8a\u6cbb\u7652\u7387\u65b9\u9762\u6709\u986f\u8457\u63d0\u5347\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u4e26\u5728\u6574\u500b\u81e8\u5e8a\u7814\u7a76\u9805\u76ee\u4e2d\u5747\u8868\u73fe\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u7279\u5fb5\u3002\u518d\u9f0e\u91ab\u85e5\u53c3\u8207\u4e86ATTACK\u5168\u7403\u7814\u7a76\uff0c\u5728\u4e2d\u570b\u62db\u52df\u60a3\u8005\u3002\u4e2d\u570b\u60a3\u8005\u968a\u5217\u6578\u64da\u8b49\u5be6\u4e86\u5168\u7403\u7814\u7a76\u4e2d\u95dc\u65bc\u6b7b\u4ea1\u7387\u548c\u81e8\u5e8a\u61c9\u7b54\u6539\u5584\u7684\u7d50\u679c\u3002 2023\u5e745\u6708\uff0cInnoviva Specialty Therapeutics\u5ba3\u4f48\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u6279\u51c6\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u7684\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u7684\u6210\u4eba\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff0c\u9019\u662fFDA\u6279\u51c6\u7684\u9996\u6b3e\u9776\u5411\u91dd\u5c0d\u8a72\u75c5\u539f\u9ad4\u7684\u7642\u6cd5\u3002 \u95dc\u65bc\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09 \u975c\u8108\u8f38\u6ce8\u578b\u7d44\u5408\u85e5\u7269\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7531Entasis Therapeutics\uff08Innoviva Specialty Therapeutics\u7684\u4e00\u5bb6\u95dc\u806f\u516c\u53f8\uff09\u958b\u767c\uff0c\u662f\u7531\u8212\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u985e\u6297\u751f\u7d20\uff09\u548c\u5ea6\u6d1b\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u9176\u6291\u5236\u5291\uff09\u7d44\u5408\u800c\u6210\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5167\u5730\u7372\u6279\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u768418\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7684\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\/VABP\uff09\u3002\u518d\u9f0e\u91ab\u85e5\u64c1\u6709\u5728\u5927\u4e2d\u83ef\u5340\uff08\u4e2d\u570b\u5167\u5730\u3001\u9999\u6e2f\u3001\u53f0\u7063\u5730\u5340\u548c\u6fb3\u9580\u7684\u5408\u7a31\uff09\u3001\u97d3\u570b\u3001\u8d8a\u5357\u3001\u6cf0\u570b\u3001\u67ec\u57d4\u5be8\u3001\u8001\u64be\u3001\u99ac\u4f86\u897f\u4e9e\u3001\u5370\u5ea6\u5c3c\u897f\u4e9e\u3001\u83f2\u5f8b\u8cd3\u3001\u65b0\u52a0\u5761\u3001\u6fb3\u5927\u5229\u4e9e\u3001\u65b0\u897f\u862d\u548c\u65e5\u672c\u958b\u767c\u548c\u5546\u696d\u5316\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7368\u4f54\u8a31\u53ef\u3002 \u95dc\u65bc\u4e0d\u52d5\u687f\u83cc \u9b91\u66fc\u4e0d\u52d5\u687f\u83cc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\uff08\u4e0d\u52d5\u687f\u83cc\uff09\u662f\u9769\u862d\u6c0f\u9670\u6027\u3001\u4eba\u985e\u6a5f\u6703\u6027\u611f\u67d3\u75c5\u539f\u9ad4\uff0c\u4e3b\u8981\u611f\u67d3\u91cd\u75c7\u60a3\u8005\uff0c\u901a\u5e38\u6703\u5c0e\u81f4\u56b4\u91cd\u7684\u80ba\u708e\u548c\u8840\u6d41\u611f\u67d3\u3002\u5b83\u5011\u9084\u53ef\u4ee5\u611f\u67d3\u5176\u4ed6\u8eab\u9ad4\u90e8\u4f4d\uff0c\u4f8b\u5982\u6ccc\u5c3f\u9053\u548c\u76ae\u819a\u3002\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u88ab\u8a8d\u70ba\u662f\u4e00\u7a2e\u5168\u7403\u6027\u7684\u516c\u5171\u885b\u751f\u5a01\u8105\uff0c\u90e8\u5206\u539f\u56e0\u662f\u5176\u80fd\u5920\u7372\u5f97\u591a\u91cd\u8010\u85e5\u6027\u3002\u4e0d\u52d5\u687f\u83cc\u5c0d\u9752\u9ef4\u7d20\u985e\u85e5\u7269\u5177\u6709\u8010\u85e5\u6027\uff0c\u4e26\u4e14\u9084\u7372\u5f97\u4e86\u5c0d\u5e7e\u4e4e\u6240\u6709\u7528\u65bc\u6cbb\u7642\u9769\u862d\u6c0f\u9670\u6027\u83cc\u7684\u6297\u751f\u7d20\u7684\u8010\u85e5\u57fa\u56e0\uff0c\u5305\u62ec\u6c1f\u594e\u8afe\u916e\u985e\u85e5\u7269\u3001\u6c28\u57fa\u7cd6\u7518\u985e\u85e5\u7269\u3001\u982d\u5b62\u83cc\u7d20\u985e\u85e5\u7269\u548c\u78b3\u9752\u9709\u70ef\u985e\u85e5\u7269\u3002 \u7f8e\u570b\u75be\u75c5\u63a7\u5236\u8207\u9810\u9632\u4e2d\u5fc3\uff08CDC\uff09\u5df2\u5c07\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u5fae\u751f\u7269\u5217\u70ba\u7dca\u8feb\u5a01\u8105\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u662f2019\u5e74\u8207\u8010\u85e5\u6027\u76f8\u95dc\u7684\u6b7b\u4ea1\u7684\u516d\u5927\u4e3b\u8981\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u88ab\u4e16\u754c\u885b\u751f\u7d44\u7e54\u5217\u70ba\u512a\u5148\u7684\u75c5\u539f\u9ad4\u3002 \u5728\u7f8e\u570b\uff0c\u6bcf\u5e74\u9810\u8a08\u7d04\u670940,000\u5230800,000\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0440%\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc,\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u6bcf\u5e74\u7d04\u6709100\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d04\u4e09\u5206\u4e4b\u4e8c\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u3002\u5168\u7403\u6bcf\u5e74\u6709\u8d85\u904e300,000\u4f8b\u6b7b\u4ea1\u8207\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u6709\u95dc\u3002 \u95dc\u65bc\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5728\u4e2d\u570b \u6839\u64daCARSS\uff08\u5168\u570b\u7d30\u83cc\u8010\u85e5\u76e3\u6e2c\u7db2\uff092022\u5e74\u5e74\u5ea6\u5831\u544a\uff0c\u4e2d\u570b\u5167\u5730\u7d04\u670930\u842c\u4f8b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5831\u544a\u3002\u6839\u64da\u6700\u65b0\u7684CHINET\u5831\u544a\uff0c\u4e2d\u570b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u6297\u751f\u7d20\u7684\u8010\u85e5\u7387\u5df2\u5347\u81f3\u7d0474%\u3002\u5728\u4e2d\u570b\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u4e5f\u662f\u5c0e\u81f4\u91ab\u9662\u7372\u5f97\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u80ba\u708e\u7684\u5e38\u898b\u75c5\u539f\u9ad4\u3002\u5728\u63d0\u4f9b\u73fe\u6709\u6cbb\u7642\u7684\u60c5\u6cc1\u4e0b\uff0c\u5176\u5728\u4e2d\u570b\u548c\u6771\u4e9e\u7684\u6b7b\u4ea1\u7387\u5206\u5225\u7d04\u70ba38%\u548c43%\u3002           Tala, B., Jad, A., Claude, A., Jihad, I., Chantal, L., Rakan, N.,&amp; Eid, A. (2017). Risk Factors, Clinical Presentation, and Outcome of\u202fAcinetobacter         Centers for Disease Control and Prevention, &quot;Carbapenem-resistant\u202fAcinetobacter baumannii\u202f(CRAB): An urgent public health threat in\u202fUnited States\u202fhealthcare facilities,&quot;\u202fAugust 2021:\u202fhttps:\/\/arpsp.cdc.gov\/story\/cra-urgent-public-health-threat         Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext         World Health Organization, &quot;WHO publishes list of bacteria for which new antibiotics are urgently needed,&quot; February 27, 2017: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed         Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discov. 2013 Dec;12(12):963. doi: 10.1038\/nrd3957-c1. Epub 2013 Nov 15.         Centers for Disease Control and Prevention. Antibiotic Resistance &amp; Patient Safety Portal. &quot;Carbapenem-resistant Acinetobacter,&quot; May 2023: https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/carbapenem-resistant-acinetobacter         Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655. Supplementary Material. Supplementary appendix.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext         China Diagnosis and Treatment Guideline for hospital-acquired pneumonia and ventilator-associated pneumonia, 2018;\u00a0         Chung DR, et al; Asian Network for Surveillance of Resistant Pathogens Study Group. Am J Respir Crit Care Med 2011; Du, et al. American Journal of Infection Control 00 (2019).         \u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pingtungtimes.com.tw\/?p=237997\" \/>\n<meta property=\"og:site_name\" content=\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pingtungnews\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-20T08:11:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n<meta name=\"author\" content=\"\u7f8e\u901a\u793e\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005:\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u7f8e\u901a\u793e\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9810\u4f30\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997\"},\"author\":{\"name\":\"\u7f8e\u901a\u793e\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\"},\"headline\":\"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02\",\"datePublished\":\"2024-05-20T08:11:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997\"},\"wordCount\":262,\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"articleSection\":[\"\u7f8e\u901a\u793e\"],\"inLanguage\":\"zh-TW\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997\",\"name\":\"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"datePublished\":\"2024-05-20T08:11:00+00:00\",\"description\":\"\u6839\u64da\u4e16\u885b\u7d44\u7e54\uff0c\u8010\u85e5\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u5168\u7403\u5065\u5eb7\u7684\u5a01\u8105\u65e5\u76ca\u7dca\u8feb\uff0c\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4 \u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u7684\u6279\u51c6\u662f\u57fa\u65bc\u5168\u9762\u7684\u81e8\u5e8a\u6578\u64da\uff0c\u8b49\u660eSUL-DUR\u5c0d\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u83cc\u682a\u5177\u6709\u826f\u597d\u7684\u6d3b\u6027 \u4e2d\u570b\u7d04\u670930\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0474%\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5 \u4e0a\u6d77\u548c\u99ac\u85a9\u8af8\u585e\u5dde\u528d\u6a4b2024\u5e745\u670820\u65e5 \\\/\u7f8e\u901a\u793e\\\/ -- \u518d\u9f0e\u91ab\u85e5\u6709\u9650\u516c\u53f8\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aZLAB\uff1b\u9999\u6e2f\u806f\u4ea4\u6240\u80a1\u4efd\u4ee3\u865f\uff1a9688\uff09\u548cInnoviva Specialty Therapeutics\u4eca\u65e5\u5ba3\u4f48\uff0c\u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u5df2\u7d93\u6279\u51c6\u4e86\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0cSUL-DUR\uff09\u7684\u65b0\u85e5\u4e0a\u5e02\u7533\u8acb\uff0c\u7528\u65bc\u6cbb\u764218\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u6240\u81f4\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\uff09\u3001\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08VABP\uff09\u3002\u4e16\u754c\u885b\u751f\u7d44\u7e54\u8a8d\u70ba\u4e0d\u52d5\u687f\u83cc\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002 \u518d\u9f0e\u91ab\u85e5\u7e3d\u88c1\uff0c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u3001\u81ea\u8eab\u514d\u75ab\u53ca\u611f\u67d3\u6027\u75be\u75c5\u9818\u57df\u5168\u7403\u958b\u767c\u8ca0\u8cac\u4eba\u4efb\u6d77\u777f\u535a\u58eb\u8868\u793a\uff1a\u300c \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7372\u5f97\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u7684\u6279\u51c6\uff0c\u51f8\u986f\u4e86\u518d\u9f0e\u81f4\u529b\u65bc\u958b\u767c\u548c\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u4ee5\u6eff\u8db3\u4e2d\u570b\u548c\u5168\u7403\u60a3\u8005\u7684\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u3002\u5c0d\u65bc\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5c0d\u516c\u773e\u7684\u5a01\u8105\uff0c\u6211\u5011\u4e9f\u9700\u63a1\u53d6\u884c\u52d5\uff0c\u56e0\u70ba\u60a3\u8005\u7684\u6cbb\u7642\u9078\u64c7\u6709\u9650\uff0c\u6b7b\u4ea1\u7387\u9ad8\u3002\u6211\u5011\u5805\u4fe1\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7372\u6279\u4ee3\u8868\u4e86\u6211\u5011\u5728\u60a3\u8005\u5b58\u5728\u5de8\u5927\u9700\u6c42\u7684\u9818\u57df\u53c8\u5411\u524d\u9081\u9032\u4e86\u4e00\u6b65\u3002\u300d\u00a0 \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u4e2d\u570b\u7372\u6279\u662f\u57fa\u65bcATTACK\u7814\u7a76\uff08NCT03894046\uff09\u7684\u7a4d\u6975\u7d50\u679c\uff0c\u8a72\u7814\u7a76\u662f\u4e00\u9805\u5168\u74033\u671f\u8a3b\u518a\u6027\u7814\u7a76\uff0c\u8a55\u4f30\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209v.s\u591a\u7c98\u83cc\u7d20E\u7528\u65bc\u6cbb\u7642\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u5728\u8a72\u7814\u7a76\u4e2d\uff0c\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u7814\u7a76\u4e3b\u8981\u7d42\u9ede\uff0c\u5373\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u768428\u5929\u5168\u56e0\u6b7b\u4ea1\u7387\u65b9\u9762\uff0c\u8207\u591a\u7c98\u83cc\u7d20E\u76f8\u6bd4\u5177\u6709\u7d71\u8a08\u5b78\u4e0a\u7684\u975e\u52a3\u6548\u6027\uff0c\u4e26\u4e14\u5728\u81e8\u5e8a\u6cbb\u7652\u7387\u65b9\u9762\u6709\u986f\u8457\u63d0\u5347\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u4e26\u5728\u6574\u500b\u81e8\u5e8a\u7814\u7a76\u9805\u76ee\u4e2d\u5747\u8868\u73fe\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u7279\u5fb5\u3002\u518d\u9f0e\u91ab\u85e5\u53c3\u8207\u4e86ATTACK\u5168\u7403\u7814\u7a76\uff0c\u5728\u4e2d\u570b\u62db\u52df\u60a3\u8005\u3002\u4e2d\u570b\u60a3\u8005\u968a\u5217\u6578\u64da\u8b49\u5be6\u4e86\u5168\u7403\u7814\u7a76\u4e2d\u95dc\u65bc\u6b7b\u4ea1\u7387\u548c\u81e8\u5e8a\u61c9\u7b54\u6539\u5584\u7684\u7d50\u679c\u3002 2023\u5e745\u6708\uff0cInnoviva Specialty Therapeutics\u5ba3\u4f48\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u6279\u51c6\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u7684\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u7684\u6210\u4eba\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff0c\u9019\u662fFDA\u6279\u51c6\u7684\u9996\u6b3e\u9776\u5411\u91dd\u5c0d\u8a72\u75c5\u539f\u9ad4\u7684\u7642\u6cd5\u3002 \u95dc\u65bc\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09 \u975c\u8108\u8f38\u6ce8\u578b\u7d44\u5408\u85e5\u7269\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7531Entasis Therapeutics\uff08Innoviva Specialty Therapeutics\u7684\u4e00\u5bb6\u95dc\u806f\u516c\u53f8\uff09\u958b\u767c\uff0c\u662f\u7531\u8212\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u985e\u6297\u751f\u7d20\uff09\u548c\u5ea6\u6d1b\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u9176\u6291\u5236\u5291\uff09\u7d44\u5408\u800c\u6210\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5167\u5730\u7372\u6279\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u768418\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7684\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\\\/VABP\uff09\u3002\u518d\u9f0e\u91ab\u85e5\u64c1\u6709\u5728\u5927\u4e2d\u83ef\u5340\uff08\u4e2d\u570b\u5167\u5730\u3001\u9999\u6e2f\u3001\u53f0\u7063\u5730\u5340\u548c\u6fb3\u9580\u7684\u5408\u7a31\uff09\u3001\u97d3\u570b\u3001\u8d8a\u5357\u3001\u6cf0\u570b\u3001\u67ec\u57d4\u5be8\u3001\u8001\u64be\u3001\u99ac\u4f86\u897f\u4e9e\u3001\u5370\u5ea6\u5c3c\u897f\u4e9e\u3001\u83f2\u5f8b\u8cd3\u3001\u65b0\u52a0\u5761\u3001\u6fb3\u5927\u5229\u4e9e\u3001\u65b0\u897f\u862d\u548c\u65e5\u672c\u958b\u767c\u548c\u5546\u696d\u5316\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7368\u4f54\u8a31\u53ef\u3002 \u95dc\u65bc\u4e0d\u52d5\u687f\u83cc \u9b91\u66fc\u4e0d\u52d5\u687f\u83cc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\uff08\u4e0d\u52d5\u687f\u83cc\uff09\u662f\u9769\u862d\u6c0f\u9670\u6027\u3001\u4eba\u985e\u6a5f\u6703\u6027\u611f\u67d3\u75c5\u539f\u9ad4\uff0c\u4e3b\u8981\u611f\u67d3\u91cd\u75c7\u60a3\u8005\uff0c\u901a\u5e38\u6703\u5c0e\u81f4\u56b4\u91cd\u7684\u80ba\u708e\u548c\u8840\u6d41\u611f\u67d3\u3002\u5b83\u5011\u9084\u53ef\u4ee5\u611f\u67d3\u5176\u4ed6\u8eab\u9ad4\u90e8\u4f4d\uff0c\u4f8b\u5982\u6ccc\u5c3f\u9053\u548c\u76ae\u819a\u3002\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u88ab\u8a8d\u70ba\u662f\u4e00\u7a2e\u5168\u7403\u6027\u7684\u516c\u5171\u885b\u751f\u5a01\u8105\uff0c\u90e8\u5206\u539f\u56e0\u662f\u5176\u80fd\u5920\u7372\u5f97\u591a\u91cd\u8010\u85e5\u6027\u3002\u4e0d\u52d5\u687f\u83cc\u5c0d\u9752\u9ef4\u7d20\u985e\u85e5\u7269\u5177\u6709\u8010\u85e5\u6027\uff0c\u4e26\u4e14\u9084\u7372\u5f97\u4e86\u5c0d\u5e7e\u4e4e\u6240\u6709\u7528\u65bc\u6cbb\u7642\u9769\u862d\u6c0f\u9670\u6027\u83cc\u7684\u6297\u751f\u7d20\u7684\u8010\u85e5\u57fa\u56e0\uff0c\u5305\u62ec\u6c1f\u594e\u8afe\u916e\u985e\u85e5\u7269\u3001\u6c28\u57fa\u7cd6\u7518\u985e\u85e5\u7269\u3001\u982d\u5b62\u83cc\u7d20\u985e\u85e5\u7269\u548c\u78b3\u9752\u9709\u70ef\u985e\u85e5\u7269\u3002 \u7f8e\u570b\u75be\u75c5\u63a7\u5236\u8207\u9810\u9632\u4e2d\u5fc3\uff08CDC\uff09\u5df2\u5c07\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u5fae\u751f\u7269\u5217\u70ba\u7dca\u8feb\u5a01\u8105\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u662f2019\u5e74\u8207\u8010\u85e5\u6027\u76f8\u95dc\u7684\u6b7b\u4ea1\u7684\u516d\u5927\u4e3b\u8981\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u88ab\u4e16\u754c\u885b\u751f\u7d44\u7e54\u5217\u70ba\u512a\u5148\u7684\u75c5\u539f\u9ad4\u3002 \u5728\u7f8e\u570b\uff0c\u6bcf\u5e74\u9810\u8a08\u7d04\u670940,000\u5230800,000\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0440%\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc,\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u6bcf\u5e74\u7d04\u6709100\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d04\u4e09\u5206\u4e4b\u4e8c\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u3002\u5168\u7403\u6bcf\u5e74\u6709\u8d85\u904e300,000\u4f8b\u6b7b\u4ea1\u8207\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u6709\u95dc\u3002 \u95dc\u65bc\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5728\u4e2d\u570b \u6839\u64daCARSS\uff08\u5168\u570b\u7d30\u83cc\u8010\u85e5\u76e3\u6e2c\u7db2\uff092022\u5e74\u5e74\u5ea6\u5831\u544a\uff0c\u4e2d\u570b\u5167\u5730\u7d04\u670930\u842c\u4f8b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5831\u544a\u3002\u6839\u64da\u6700\u65b0\u7684CHINET\u5831\u544a\uff0c\u4e2d\u570b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u6297\u751f\u7d20\u7684\u8010\u85e5\u7387\u5df2\u5347\u81f3\u7d0474%\u3002\u5728\u4e2d\u570b\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u4e5f\u662f\u5c0e\u81f4\u91ab\u9662\u7372\u5f97\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u80ba\u708e\u7684\u5e38\u898b\u75c5\u539f\u9ad4\u3002\u5728\u63d0\u4f9b\u73fe\u6709\u6cbb\u7642\u7684\u60c5\u6cc1\u4e0b\uff0c\u5176\u5728\u4e2d\u570b\u548c\u6771\u4e9e\u7684\u6b7b\u4ea1\u7387\u5206\u5225\u7d04\u70ba38%\u548c43%\u3002 Tala, B., Jad, A., Claude, A., Jihad, I., Chantal, L., Rakan, N.,&amp; Eid, A. (2017). Risk Factors, Clinical Presentation, and Outcome of\u202fAcinetobacter Centers for Disease Control and Prevention, \\\"Carbapenem-resistant\u202fAcinetobacter baumannii\u202f(CRAB): An urgent public health threat in\u202fUnited States\u202fhealthcare facilities,\\\"\u202fAugust 2021:\u202fhttps:\\\/\\\/arpsp.cdc.gov\\\/story\\\/cra-urgent-public-health-threat Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655.\u202fhttps:\\\/\\\/www.thelancet.com\\\/journals\\\/lancet\\\/article\\\/PIIS0140-6736(21)02724-0\\\/fulltext World Health Organization, \\\"WHO publishes list of bacteria for which new antibiotics are urgently needed,\\\" February 27, 2017: https:\\\/\\\/www.who.int\\\/news\\\/item\\\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discov. 2013 Dec;12(12):963. doi: 10.1038\\\/nrd3957-c1. Epub 2013 Nov 15. Centers for Disease Control and Prevention. Antibiotic Resistance &amp; Patient Safety Portal. \\\"Carbapenem-resistant Acinetobacter,\\\" May 2023: https:\\\/\\\/arpsp.cdc.gov\\\/profile\\\/antibiotic-resistance\\\/carbapenem-resistant-acinetobacter Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655. Supplementary Material. Supplementary appendix.\u202fhttps:\\\/\\\/www.thelancet.com\\\/journals\\\/lancet\\\/article\\\/PIIS0140-6736(21)02724-0\\\/fulltext China Diagnosis and Treatment Guideline for hospital-acquired pneumonia and ventilator-associated pneumonia, 2018;\u00a0 Chung DR, et al; Asian Network for Surveillance of Resistant Pathogens Study Group. Am J Respir Crit Care Med 2011; Du, et al. American Journal of Infection Control 00 (2019). \u00a0\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997#breadcrumb\"},\"inLanguage\":\"zh-TW\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997#primaryimage\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":\"3000\",\"height\":\"1990\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?p=237997#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9801\",\"item\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#website\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"description\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4\",\"publisher\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-TW\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#organization\",\"name\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"contentUrl\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/logo-150.png\",\"width\":150,\"height\":150,\"caption\":\"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831\"},\"image\":{\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pingtungnews\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/#\\\/schema\\\/person\\\/683b937f29ec1537972f6c41e22a2cf3\",\"name\":\"\u7f8e\u901a\u793e\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-TW\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g\",\"caption\":\"\u7f8e\u901a\u793e\"},\"url\":\"https:\\\/\\\/pingtungtimes.com.tw\\\/?author=16\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u6839\u64da\u4e16\u885b\u7d44\u7e54\uff0c\u8010\u85e5\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u5168\u7403\u5065\u5eb7\u7684\u5a01\u8105\u65e5\u76ca\u7dca\u8feb\uff0c\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4  \u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u7684\u6279\u51c6\u662f\u57fa\u65bc\u5168\u9762\u7684\u81e8\u5e8a\u6578\u64da\uff0c\u8b49\u660eSUL-DUR\u5c0d\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u83cc\u682a\u5177\u6709\u826f\u597d\u7684\u6d3b\u6027  \u4e2d\u570b\u7d04\u670930\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0474%\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5  \u4e0a\u6d77\u548c\u99ac\u85a9\u8af8\u585e\u5dde\u528d\u6a4b2024\u5e745\u670820\u65e5 \/\u7f8e\u901a\u793e\/ -- \u518d\u9f0e\u91ab\u85e5\u6709\u9650\u516c\u53f8\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aZLAB\uff1b\u9999\u6e2f\u806f\u4ea4\u6240\u80a1\u4efd\u4ee3\u865f\uff1a9688\uff09\u548cInnoviva Specialty Therapeutics\u4eca\u65e5\u5ba3\u4f48\uff0c\u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u5df2\u7d93\u6279\u51c6\u4e86\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0cSUL-DUR\uff09\u7684\u65b0\u85e5\u4e0a\u5e02\u7533\u8acb\uff0c\u7528\u65bc\u6cbb\u764218\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u6240\u81f4\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\uff09\u3001\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08VABP\uff09\u3002\u4e16\u754c\u885b\u751f\u7d44\u7e54\u8a8d\u70ba\u4e0d\u52d5\u687f\u83cc\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002 \u518d\u9f0e\u91ab\u85e5\u7e3d\u88c1\uff0c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u3001\u81ea\u8eab\u514d\u75ab\u53ca\u611f\u67d3\u6027\u75be\u75c5\u9818\u57df\u5168\u7403\u958b\u767c\u8ca0\u8cac\u4eba\u4efb\u6d77\u777f\u535a\u58eb\u8868\u793a\uff1a\u300c \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7372\u5f97\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u7684\u6279\u51c6\uff0c\u51f8\u986f\u4e86\u518d\u9f0e\u81f4\u529b\u65bc\u958b\u767c\u548c\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u4ee5\u6eff\u8db3\u4e2d\u570b\u548c\u5168\u7403\u60a3\u8005\u7684\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u3002\u5c0d\u65bc\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5c0d\u516c\u773e\u7684\u5a01\u8105\uff0c\u6211\u5011\u4e9f\u9700\u63a1\u53d6\u884c\u52d5\uff0c\u56e0\u70ba\u60a3\u8005\u7684\u6cbb\u7642\u9078\u64c7\u6709\u9650\uff0c\u6b7b\u4ea1\u7387\u9ad8\u3002\u6211\u5011\u5805\u4fe1\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7372\u6279\u4ee3\u8868\u4e86\u6211\u5011\u5728\u60a3\u8005\u5b58\u5728\u5de8\u5927\u9700\u6c42\u7684\u9818\u57df\u53c8\u5411\u524d\u9081\u9032\u4e86\u4e00\u6b65\u3002\u300d\u00a0 \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u4e2d\u570b\u7372\u6279\u662f\u57fa\u65bcATTACK\u7814\u7a76\uff08NCT03894046\uff09\u7684\u7a4d\u6975\u7d50\u679c\uff0c\u8a72\u7814\u7a76\u662f\u4e00\u9805\u5168\u74033\u671f\u8a3b\u518a\u6027\u7814\u7a76\uff0c\u8a55\u4f30\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209v.s\u591a\u7c98\u83cc\u7d20E\u7528\u65bc\u6cbb\u7642\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u5728\u8a72\u7814\u7a76\u4e2d\uff0c\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u7814\u7a76\u4e3b\u8981\u7d42\u9ede\uff0c\u5373\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u768428\u5929\u5168\u56e0\u6b7b\u4ea1\u7387\u65b9\u9762\uff0c\u8207\u591a\u7c98\u83cc\u7d20E\u76f8\u6bd4\u5177\u6709\u7d71\u8a08\u5b78\u4e0a\u7684\u975e\u52a3\u6548\u6027\uff0c\u4e26\u4e14\u5728\u81e8\u5e8a\u6cbb\u7652\u7387\u65b9\u9762\u6709\u986f\u8457\u63d0\u5347\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u4e26\u5728\u6574\u500b\u81e8\u5e8a\u7814\u7a76\u9805\u76ee\u4e2d\u5747\u8868\u73fe\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u7279\u5fb5\u3002\u518d\u9f0e\u91ab\u85e5\u53c3\u8207\u4e86ATTACK\u5168\u7403\u7814\u7a76\uff0c\u5728\u4e2d\u570b\u62db\u52df\u60a3\u8005\u3002\u4e2d\u570b\u60a3\u8005\u968a\u5217\u6578\u64da\u8b49\u5be6\u4e86\u5168\u7403\u7814\u7a76\u4e2d\u95dc\u65bc\u6b7b\u4ea1\u7387\u548c\u81e8\u5e8a\u61c9\u7b54\u6539\u5584\u7684\u7d50\u679c\u3002 2023\u5e745\u6708\uff0cInnoviva Specialty Therapeutics\u5ba3\u4f48\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u6279\u51c6\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u7684\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u7684\u6210\u4eba\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff0c\u9019\u662fFDA\u6279\u51c6\u7684\u9996\u6b3e\u9776\u5411\u91dd\u5c0d\u8a72\u75c5\u539f\u9ad4\u7684\u7642\u6cd5\u3002 \u95dc\u65bc\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09 \u975c\u8108\u8f38\u6ce8\u578b\u7d44\u5408\u85e5\u7269\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7531Entasis Therapeutics\uff08Innoviva Specialty Therapeutics\u7684\u4e00\u5bb6\u95dc\u806f\u516c\u53f8\uff09\u958b\u767c\uff0c\u662f\u7531\u8212\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u985e\u6297\u751f\u7d20\uff09\u548c\u5ea6\u6d1b\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u9176\u6291\u5236\u5291\uff09\u7d44\u5408\u800c\u6210\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5167\u5730\u7372\u6279\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u768418\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7684\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\/VABP\uff09\u3002\u518d\u9f0e\u91ab\u85e5\u64c1\u6709\u5728\u5927\u4e2d\u83ef\u5340\uff08\u4e2d\u570b\u5167\u5730\u3001\u9999\u6e2f\u3001\u53f0\u7063\u5730\u5340\u548c\u6fb3\u9580\u7684\u5408\u7a31\uff09\u3001\u97d3\u570b\u3001\u8d8a\u5357\u3001\u6cf0\u570b\u3001\u67ec\u57d4\u5be8\u3001\u8001\u64be\u3001\u99ac\u4f86\u897f\u4e9e\u3001\u5370\u5ea6\u5c3c\u897f\u4e9e\u3001\u83f2\u5f8b\u8cd3\u3001\u65b0\u52a0\u5761\u3001\u6fb3\u5927\u5229\u4e9e\u3001\u65b0\u897f\u862d\u548c\u65e5\u672c\u958b\u767c\u548c\u5546\u696d\u5316\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7368\u4f54\u8a31\u53ef\u3002 \u95dc\u65bc\u4e0d\u52d5\u687f\u83cc \u9b91\u66fc\u4e0d\u52d5\u687f\u83cc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\uff08\u4e0d\u52d5\u687f\u83cc\uff09\u662f\u9769\u862d\u6c0f\u9670\u6027\u3001\u4eba\u985e\u6a5f\u6703\u6027\u611f\u67d3\u75c5\u539f\u9ad4\uff0c\u4e3b\u8981\u611f\u67d3\u91cd\u75c7\u60a3\u8005\uff0c\u901a\u5e38\u6703\u5c0e\u81f4\u56b4\u91cd\u7684\u80ba\u708e\u548c\u8840\u6d41\u611f\u67d3\u3002\u5b83\u5011\u9084\u53ef\u4ee5\u611f\u67d3\u5176\u4ed6\u8eab\u9ad4\u90e8\u4f4d\uff0c\u4f8b\u5982\u6ccc\u5c3f\u9053\u548c\u76ae\u819a\u3002\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u88ab\u8a8d\u70ba\u662f\u4e00\u7a2e\u5168\u7403\u6027\u7684\u516c\u5171\u885b\u751f\u5a01\u8105\uff0c\u90e8\u5206\u539f\u56e0\u662f\u5176\u80fd\u5920\u7372\u5f97\u591a\u91cd\u8010\u85e5\u6027\u3002\u4e0d\u52d5\u687f\u83cc\u5c0d\u9752\u9ef4\u7d20\u985e\u85e5\u7269\u5177\u6709\u8010\u85e5\u6027\uff0c\u4e26\u4e14\u9084\u7372\u5f97\u4e86\u5c0d\u5e7e\u4e4e\u6240\u6709\u7528\u65bc\u6cbb\u7642\u9769\u862d\u6c0f\u9670\u6027\u83cc\u7684\u6297\u751f\u7d20\u7684\u8010\u85e5\u57fa\u56e0\uff0c\u5305\u62ec\u6c1f\u594e\u8afe\u916e\u985e\u85e5\u7269\u3001\u6c28\u57fa\u7cd6\u7518\u985e\u85e5\u7269\u3001\u982d\u5b62\u83cc\u7d20\u985e\u85e5\u7269\u548c\u78b3\u9752\u9709\u70ef\u985e\u85e5\u7269\u3002 \u7f8e\u570b\u75be\u75c5\u63a7\u5236\u8207\u9810\u9632\u4e2d\u5fc3\uff08CDC\uff09\u5df2\u5c07\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u5fae\u751f\u7269\u5217\u70ba\u7dca\u8feb\u5a01\u8105\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u662f2019\u5e74\u8207\u8010\u85e5\u6027\u76f8\u95dc\u7684\u6b7b\u4ea1\u7684\u516d\u5927\u4e3b\u8981\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u88ab\u4e16\u754c\u885b\u751f\u7d44\u7e54\u5217\u70ba\u512a\u5148\u7684\u75c5\u539f\u9ad4\u3002 \u5728\u7f8e\u570b\uff0c\u6bcf\u5e74\u9810\u8a08\u7d04\u670940,000\u5230800,000\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0440%\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc,\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u6bcf\u5e74\u7d04\u6709100\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d04\u4e09\u5206\u4e4b\u4e8c\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u3002\u5168\u7403\u6bcf\u5e74\u6709\u8d85\u904e300,000\u4f8b\u6b7b\u4ea1\u8207\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u6709\u95dc\u3002 \u95dc\u65bc\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5728\u4e2d\u570b \u6839\u64daCARSS\uff08\u5168\u570b\u7d30\u83cc\u8010\u85e5\u76e3\u6e2c\u7db2\uff092022\u5e74\u5e74\u5ea6\u5831\u544a\uff0c\u4e2d\u570b\u5167\u5730\u7d04\u670930\u842c\u4f8b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5831\u544a\u3002\u6839\u64da\u6700\u65b0\u7684CHINET\u5831\u544a\uff0c\u4e2d\u570b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u6297\u751f\u7d20\u7684\u8010\u85e5\u7387\u5df2\u5347\u81f3\u7d0474%\u3002\u5728\u4e2d\u570b\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u4e5f\u662f\u5c0e\u81f4\u91ab\u9662\u7372\u5f97\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u80ba\u708e\u7684\u5e38\u898b\u75c5\u539f\u9ad4\u3002\u5728\u63d0\u4f9b\u73fe\u6709\u6cbb\u7642\u7684\u60c5\u6cc1\u4e0b\uff0c\u5176\u5728\u4e2d\u570b\u548c\u6771\u4e9e\u7684\u6b7b\u4ea1\u7387\u5206\u5225\u7d04\u70ba38%\u548c43%\u3002           Tala, B., Jad, A., Claude, A., Jihad, I., Chantal, L., Rakan, N.,&amp; Eid, A. (2017). Risk Factors, Clinical Presentation, and Outcome of\u202fAcinetobacter         Centers for Disease Control and Prevention, \"Carbapenem-resistant\u202fAcinetobacter baumannii\u202f(CRAB): An urgent public health threat in\u202fUnited States\u202fhealthcare facilities,\"\u202fAugust 2021:\u202fhttps:\/\/arpsp.cdc.gov\/story\/cra-urgent-public-health-threat         Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext         World Health Organization, \"WHO publishes list of bacteria for which new antibiotics are urgently needed,\" February 27, 2017: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed         Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discov. 2013 Dec;12(12):963. doi: 10.1038\/nrd3957-c1. Epub 2013 Nov 15.         Centers for Disease Control and Prevention. Antibiotic Resistance &amp; Patient Safety Portal. \"Carbapenem-resistant Acinetobacter,\" May 2023: https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/carbapenem-resistant-acinetobacter         Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655. Supplementary Material. Supplementary appendix.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext         China Diagnosis and Treatment Guideline for hospital-acquired pneumonia and ventilator-associated pneumonia, 2018;\u00a0         Chung DR, et al; Asian Network for Surveillance of Resistant Pathogens Study Group. Am J Respir Crit Care Med 2011; Du, et al. American Journal of Infection Control 00 (2019).         \u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pingtungtimes.com.tw\/?p=237997","og_locale":"zh_TW","og_type":"article","og_title":"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","og_description":"\u6839\u64da\u4e16\u885b\u7d44\u7e54\uff0c\u8010\u85e5\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u5168\u7403\u5065\u5eb7\u7684\u5a01\u8105\u65e5\u76ca\u7dca\u8feb\uff0c\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4  \u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u7684\u6279\u51c6\u662f\u57fa\u65bc\u5168\u9762\u7684\u81e8\u5e8a\u6578\u64da\uff0c\u8b49\u660eSUL-DUR\u5c0d\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u83cc\u682a\u5177\u6709\u826f\u597d\u7684\u6d3b\u6027  \u4e2d\u570b\u7d04\u670930\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0474%\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5  \u4e0a\u6d77\u548c\u99ac\u85a9\u8af8\u585e\u5dde\u528d\u6a4b2024\u5e745\u670820\u65e5 \/\u7f8e\u901a\u793e\/ -- \u518d\u9f0e\u91ab\u85e5\u6709\u9650\u516c\u53f8\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aZLAB\uff1b\u9999\u6e2f\u806f\u4ea4\u6240\u80a1\u4efd\u4ee3\u865f\uff1a9688\uff09\u548cInnoviva Specialty Therapeutics\u4eca\u65e5\u5ba3\u4f48\uff0c\u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u5df2\u7d93\u6279\u51c6\u4e86\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0cSUL-DUR\uff09\u7684\u65b0\u85e5\u4e0a\u5e02\u7533\u8acb\uff0c\u7528\u65bc\u6cbb\u764218\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u6240\u81f4\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\uff09\u3001\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08VABP\uff09\u3002\u4e16\u754c\u885b\u751f\u7d44\u7e54\u8a8d\u70ba\u4e0d\u52d5\u687f\u83cc\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002 \u518d\u9f0e\u91ab\u85e5\u7e3d\u88c1\uff0c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u3001\u81ea\u8eab\u514d\u75ab\u53ca\u611f\u67d3\u6027\u75be\u75c5\u9818\u57df\u5168\u7403\u958b\u767c\u8ca0\u8cac\u4eba\u4efb\u6d77\u777f\u535a\u58eb\u8868\u793a\uff1a\u300c \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7372\u5f97\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u7684\u6279\u51c6\uff0c\u51f8\u986f\u4e86\u518d\u9f0e\u81f4\u529b\u65bc\u958b\u767c\u548c\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u4ee5\u6eff\u8db3\u4e2d\u570b\u548c\u5168\u7403\u60a3\u8005\u7684\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u3002\u5c0d\u65bc\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5c0d\u516c\u773e\u7684\u5a01\u8105\uff0c\u6211\u5011\u4e9f\u9700\u63a1\u53d6\u884c\u52d5\uff0c\u56e0\u70ba\u60a3\u8005\u7684\u6cbb\u7642\u9078\u64c7\u6709\u9650\uff0c\u6b7b\u4ea1\u7387\u9ad8\u3002\u6211\u5011\u5805\u4fe1\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7372\u6279\u4ee3\u8868\u4e86\u6211\u5011\u5728\u60a3\u8005\u5b58\u5728\u5de8\u5927\u9700\u6c42\u7684\u9818\u57df\u53c8\u5411\u524d\u9081\u9032\u4e86\u4e00\u6b65\u3002\u300d\u00a0 \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u4e2d\u570b\u7372\u6279\u662f\u57fa\u65bcATTACK\u7814\u7a76\uff08NCT03894046\uff09\u7684\u7a4d\u6975\u7d50\u679c\uff0c\u8a72\u7814\u7a76\u662f\u4e00\u9805\u5168\u74033\u671f\u8a3b\u518a\u6027\u7814\u7a76\uff0c\u8a55\u4f30\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209v.s\u591a\u7c98\u83cc\u7d20E\u7528\u65bc\u6cbb\u7642\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u5728\u8a72\u7814\u7a76\u4e2d\uff0c\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u7814\u7a76\u4e3b\u8981\u7d42\u9ede\uff0c\u5373\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u768428\u5929\u5168\u56e0\u6b7b\u4ea1\u7387\u65b9\u9762\uff0c\u8207\u591a\u7c98\u83cc\u7d20E\u76f8\u6bd4\u5177\u6709\u7d71\u8a08\u5b78\u4e0a\u7684\u975e\u52a3\u6548\u6027\uff0c\u4e26\u4e14\u5728\u81e8\u5e8a\u6cbb\u7652\u7387\u65b9\u9762\u6709\u986f\u8457\u63d0\u5347\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u4e26\u5728\u6574\u500b\u81e8\u5e8a\u7814\u7a76\u9805\u76ee\u4e2d\u5747\u8868\u73fe\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u7279\u5fb5\u3002\u518d\u9f0e\u91ab\u85e5\u53c3\u8207\u4e86ATTACK\u5168\u7403\u7814\u7a76\uff0c\u5728\u4e2d\u570b\u62db\u52df\u60a3\u8005\u3002\u4e2d\u570b\u60a3\u8005\u968a\u5217\u6578\u64da\u8b49\u5be6\u4e86\u5168\u7403\u7814\u7a76\u4e2d\u95dc\u65bc\u6b7b\u4ea1\u7387\u548c\u81e8\u5e8a\u61c9\u7b54\u6539\u5584\u7684\u7d50\u679c\u3002 2023\u5e745\u6708\uff0cInnoviva Specialty Therapeutics\u5ba3\u4f48\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u6279\u51c6\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u7684\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u7684\u6210\u4eba\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff0c\u9019\u662fFDA\u6279\u51c6\u7684\u9996\u6b3e\u9776\u5411\u91dd\u5c0d\u8a72\u75c5\u539f\u9ad4\u7684\u7642\u6cd5\u3002 \u95dc\u65bc\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09 \u975c\u8108\u8f38\u6ce8\u578b\u7d44\u5408\u85e5\u7269\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7531Entasis Therapeutics\uff08Innoviva Specialty Therapeutics\u7684\u4e00\u5bb6\u95dc\u806f\u516c\u53f8\uff09\u958b\u767c\uff0c\u662f\u7531\u8212\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u985e\u6297\u751f\u7d20\uff09\u548c\u5ea6\u6d1b\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u9176\u6291\u5236\u5291\uff09\u7d44\u5408\u800c\u6210\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5167\u5730\u7372\u6279\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u768418\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7684\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\/VABP\uff09\u3002\u518d\u9f0e\u91ab\u85e5\u64c1\u6709\u5728\u5927\u4e2d\u83ef\u5340\uff08\u4e2d\u570b\u5167\u5730\u3001\u9999\u6e2f\u3001\u53f0\u7063\u5730\u5340\u548c\u6fb3\u9580\u7684\u5408\u7a31\uff09\u3001\u97d3\u570b\u3001\u8d8a\u5357\u3001\u6cf0\u570b\u3001\u67ec\u57d4\u5be8\u3001\u8001\u64be\u3001\u99ac\u4f86\u897f\u4e9e\u3001\u5370\u5ea6\u5c3c\u897f\u4e9e\u3001\u83f2\u5f8b\u8cd3\u3001\u65b0\u52a0\u5761\u3001\u6fb3\u5927\u5229\u4e9e\u3001\u65b0\u897f\u862d\u548c\u65e5\u672c\u958b\u767c\u548c\u5546\u696d\u5316\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7368\u4f54\u8a31\u53ef\u3002 \u95dc\u65bc\u4e0d\u52d5\u687f\u83cc \u9b91\u66fc\u4e0d\u52d5\u687f\u83cc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\uff08\u4e0d\u52d5\u687f\u83cc\uff09\u662f\u9769\u862d\u6c0f\u9670\u6027\u3001\u4eba\u985e\u6a5f\u6703\u6027\u611f\u67d3\u75c5\u539f\u9ad4\uff0c\u4e3b\u8981\u611f\u67d3\u91cd\u75c7\u60a3\u8005\uff0c\u901a\u5e38\u6703\u5c0e\u81f4\u56b4\u91cd\u7684\u80ba\u708e\u548c\u8840\u6d41\u611f\u67d3\u3002\u5b83\u5011\u9084\u53ef\u4ee5\u611f\u67d3\u5176\u4ed6\u8eab\u9ad4\u90e8\u4f4d\uff0c\u4f8b\u5982\u6ccc\u5c3f\u9053\u548c\u76ae\u819a\u3002\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u88ab\u8a8d\u70ba\u662f\u4e00\u7a2e\u5168\u7403\u6027\u7684\u516c\u5171\u885b\u751f\u5a01\u8105\uff0c\u90e8\u5206\u539f\u56e0\u662f\u5176\u80fd\u5920\u7372\u5f97\u591a\u91cd\u8010\u85e5\u6027\u3002\u4e0d\u52d5\u687f\u83cc\u5c0d\u9752\u9ef4\u7d20\u985e\u85e5\u7269\u5177\u6709\u8010\u85e5\u6027\uff0c\u4e26\u4e14\u9084\u7372\u5f97\u4e86\u5c0d\u5e7e\u4e4e\u6240\u6709\u7528\u65bc\u6cbb\u7642\u9769\u862d\u6c0f\u9670\u6027\u83cc\u7684\u6297\u751f\u7d20\u7684\u8010\u85e5\u57fa\u56e0\uff0c\u5305\u62ec\u6c1f\u594e\u8afe\u916e\u985e\u85e5\u7269\u3001\u6c28\u57fa\u7cd6\u7518\u985e\u85e5\u7269\u3001\u982d\u5b62\u83cc\u7d20\u985e\u85e5\u7269\u548c\u78b3\u9752\u9709\u70ef\u985e\u85e5\u7269\u3002 \u7f8e\u570b\u75be\u75c5\u63a7\u5236\u8207\u9810\u9632\u4e2d\u5fc3\uff08CDC\uff09\u5df2\u5c07\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u5fae\u751f\u7269\u5217\u70ba\u7dca\u8feb\u5a01\u8105\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u662f2019\u5e74\u8207\u8010\u85e5\u6027\u76f8\u95dc\u7684\u6b7b\u4ea1\u7684\u516d\u5927\u4e3b\u8981\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u88ab\u4e16\u754c\u885b\u751f\u7d44\u7e54\u5217\u70ba\u512a\u5148\u7684\u75c5\u539f\u9ad4\u3002 \u5728\u7f8e\u570b\uff0c\u6bcf\u5e74\u9810\u8a08\u7d04\u670940,000\u5230800,000\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0440%\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc,\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u6bcf\u5e74\u7d04\u6709100\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d04\u4e09\u5206\u4e4b\u4e8c\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u3002\u5168\u7403\u6bcf\u5e74\u6709\u8d85\u904e300,000\u4f8b\u6b7b\u4ea1\u8207\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u6709\u95dc\u3002 \u95dc\u65bc\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5728\u4e2d\u570b \u6839\u64daCARSS\uff08\u5168\u570b\u7d30\u83cc\u8010\u85e5\u76e3\u6e2c\u7db2\uff092022\u5e74\u5e74\u5ea6\u5831\u544a\uff0c\u4e2d\u570b\u5167\u5730\u7d04\u670930\u842c\u4f8b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5831\u544a\u3002\u6839\u64da\u6700\u65b0\u7684CHINET\u5831\u544a\uff0c\u4e2d\u570b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u6297\u751f\u7d20\u7684\u8010\u85e5\u7387\u5df2\u5347\u81f3\u7d0474%\u3002\u5728\u4e2d\u570b\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u4e5f\u662f\u5c0e\u81f4\u91ab\u9662\u7372\u5f97\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u80ba\u708e\u7684\u5e38\u898b\u75c5\u539f\u9ad4\u3002\u5728\u63d0\u4f9b\u73fe\u6709\u6cbb\u7642\u7684\u60c5\u6cc1\u4e0b\uff0c\u5176\u5728\u4e2d\u570b\u548c\u6771\u4e9e\u7684\u6b7b\u4ea1\u7387\u5206\u5225\u7d04\u70ba38%\u548c43%\u3002           Tala, B., Jad, A., Claude, A., Jihad, I., Chantal, L., Rakan, N.,&amp; Eid, A. (2017). Risk Factors, Clinical Presentation, and Outcome of\u202fAcinetobacter         Centers for Disease Control and Prevention, \"Carbapenem-resistant\u202fAcinetobacter baumannii\u202f(CRAB): An urgent public health threat in\u202fUnited States\u202fhealthcare facilities,\"\u202fAugust 2021:\u202fhttps:\/\/arpsp.cdc.gov\/story\/cra-urgent-public-health-threat         Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext         World Health Organization, \"WHO publishes list of bacteria for which new antibiotics are urgently needed,\" February 27, 2017: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed         Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discov. 2013 Dec;12(12):963. doi: 10.1038\/nrd3957-c1. Epub 2013 Nov 15.         Centers for Disease Control and Prevention. Antibiotic Resistance &amp; Patient Safety Portal. \"Carbapenem-resistant Acinetobacter,\" May 2023: https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/carbapenem-resistant-acinetobacter         Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655. Supplementary Material. Supplementary appendix.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext         China Diagnosis and Treatment Guideline for hospital-acquired pneumonia and ventilator-associated pneumonia, 2018;\u00a0         Chung DR, et al; Asian Network for Surveillance of Resistant Pathogens Study Group. Am J Respir Crit Care Med 2011; Du, et al. American Journal of Infection Control 00 (2019).         \u00a0","og_url":"https:\/\/pingtungtimes.com.tw\/?p=237997","og_site_name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","article_publisher":"https:\/\/www.facebook.com\/pingtungnews","article_published_time":"2024-05-20T08:11:00+00:00","og_image":[{"url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","type":"","width":"","height":""}],"author":"\u7f8e\u901a\u793e","twitter_card":"summary_large_image","twitter_image":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","twitter_misc":{"\u4f5c\u8005:":"\u7f8e\u901a\u793e","\u9810\u4f30\u95b1\u8b80\u6642\u9593":"1 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/pingtungtimes.com.tw\/?p=237997#article","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=237997"},"author":{"name":"\u7f8e\u901a\u793e","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3"},"headline":"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02","datePublished":"2024-05-20T08:11:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=237997"},"wordCount":262,"publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=237997#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","articleSection":["\u7f8e\u901a\u793e"],"inLanguage":"zh-TW"},{"@type":"WebPage","@id":"https:\/\/pingtungtimes.com.tw\/?p=237997","url":"https:\/\/pingtungtimes.com.tw\/?p=237997","name":"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02 - \u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","isPartOf":{"@id":"https:\/\/pingtungtimes.com.tw\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=237997#primaryimage"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=237997#primaryimage"},"thumbnailUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","datePublished":"2024-05-20T08:11:00+00:00","description":"\u6839\u64da\u4e16\u885b\u7d44\u7e54\uff0c\u8010\u85e5\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u5168\u7403\u5065\u5eb7\u7684\u5a01\u8105\u65e5\u76ca\u7dca\u8feb\uff0c\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4 \u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u7684\u6279\u51c6\u662f\u57fa\u65bc\u5168\u9762\u7684\u81e8\u5e8a\u6578\u64da\uff0c\u8b49\u660eSUL-DUR\u5c0d\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u83cc\u682a\u5177\u6709\u826f\u597d\u7684\u6d3b\u6027 \u4e2d\u570b\u7d04\u670930\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0474%\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5 \u4e0a\u6d77\u548c\u99ac\u85a9\u8af8\u585e\u5dde\u528d\u6a4b2024\u5e745\u670820\u65e5 \/\u7f8e\u901a\u793e\/ -- \u518d\u9f0e\u91ab\u85e5\u6709\u9650\u516c\u53f8\uff08\u7d0d\u65af\u9054\u514b\u80a1\u7968\u4ee3\u78bc\uff1aZLAB\uff1b\u9999\u6e2f\u806f\u4ea4\u6240\u80a1\u4efd\u4ee3\u865f\uff1a9688\uff09\u548cInnoviva Specialty Therapeutics\u4eca\u65e5\u5ba3\u4f48\uff0c\u4e2d\u570b\u570b\u5bb6\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u5df2\u7d93\u6279\u51c6\u4e86\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0cSUL-DUR\uff09\u7684\u65b0\u85e5\u4e0a\u5e02\u7533\u8acb\uff0c\u7528\u65bc\u6cbb\u764218\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u6240\u81f4\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\uff09\u3001\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08VABP\uff09\u3002\u4e16\u754c\u885b\u751f\u7d44\u7e54\u8a8d\u70ba\u4e0d\u52d5\u687f\u83cc\u662f\u4e9f\u9700\u65b0\u578b\u6297\u751f\u7d20\u7684\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002 \u518d\u9f0e\u91ab\u85e5\u7e3d\u88c1\uff0c\u4e2d\u6a1e\u795e\u7d93\u7cfb\u7d71\u3001\u81ea\u8eab\u514d\u75ab\u53ca\u611f\u67d3\u6027\u75be\u75c5\u9818\u57df\u5168\u7403\u958b\u767c\u8ca0\u8cac\u4eba\u4efb\u6d77\u777f\u535a\u58eb\u8868\u793a\uff1a\u300c \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7372\u5f97\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u7684\u6279\u51c6\uff0c\u51f8\u986f\u4e86\u518d\u9f0e\u81f4\u529b\u65bc\u958b\u767c\u548c\u63d0\u4f9b\u5275\u65b0\u7642\u6cd5\uff0c\u4ee5\u6eff\u8db3\u4e2d\u570b\u548c\u5168\u7403\u60a3\u8005\u7684\u672a\u6eff\u8db3\u7684\u91ab\u7642\u9700\u6c42\u3002\u5c0d\u65bc\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5c0d\u516c\u773e\u7684\u5a01\u8105\uff0c\u6211\u5011\u4e9f\u9700\u63a1\u53d6\u884c\u52d5\uff0c\u56e0\u70ba\u60a3\u8005\u7684\u6cbb\u7642\u9078\u64c7\u6709\u9650\uff0c\u6b7b\u4ea1\u7387\u9ad8\u3002\u6211\u5011\u5805\u4fe1\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7372\u6279\u4ee3\u8868\u4e86\u6211\u5011\u5728\u60a3\u8005\u5b58\u5728\u5de8\u5927\u9700\u6c42\u7684\u9818\u57df\u53c8\u5411\u524d\u9081\u9032\u4e86\u4e00\u6b65\u3002\u300d\u00a0 \u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u4e2d\u570b\u7372\u6279\u662f\u57fa\u65bcATTACK\u7814\u7a76\uff08NCT03894046\uff09\u7684\u7a4d\u6975\u7d50\u679c\uff0c\u8a72\u7814\u7a76\u662f\u4e00\u9805\u5168\u74033\u671f\u8a3b\u518a\u6027\u7814\u7a76\uff0c\u8a55\u4f30\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209v.s\u591a\u7c98\u83cc\u7d20E\u7528\u65bc\u6cbb\u7642\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u5728\u8a72\u7814\u7a76\u4e2d\uff0c\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5728\u7814\u7a76\u4e3b\u8981\u7d42\u9ede\uff0c\u5373\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u60a3\u8005\u768428\u5929\u5168\u56e0\u6b7b\u4ea1\u7387\u65b9\u9762\uff0c\u8207\u591a\u7c98\u83cc\u7d20E\u76f8\u6bd4\u5177\u6709\u7d71\u8a08\u5b78\u4e0a\u7684\u975e\u52a3\u6548\u6027\uff0c\u4e26\u4e14\u5728\u81e8\u5e8a\u6cbb\u7652\u7387\u65b9\u9762\u6709\u986f\u8457\u63d0\u5347\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5177\u6709\u826f\u597d\u7684\u8010\u53d7\u6027\uff0c\u4e26\u5728\u6574\u500b\u81e8\u5e8a\u7814\u7a76\u9805\u76ee\u4e2d\u5747\u8868\u73fe\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u7279\u5fb5\u3002\u518d\u9f0e\u91ab\u85e5\u53c3\u8207\u4e86ATTACK\u5168\u7403\u7814\u7a76\uff0c\u5728\u4e2d\u570b\u62db\u52df\u60a3\u8005\u3002\u4e2d\u570b\u60a3\u8005\u968a\u5217\u6578\u64da\u8b49\u5be6\u4e86\u5168\u7403\u7814\u7a76\u4e2d\u95dc\u65bc\u6b7b\u4ea1\u7387\u548c\u81e8\u5e8a\u61c9\u7b54\u6539\u5584\u7684\u7d50\u679c\u3002 2023\u5e745\u6708\uff0cInnoviva Specialty Therapeutics\u5ba3\u4f48\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\u6279\u51c6\u4e86\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u7684\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u7684\u6210\u4eba\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff0c\u9019\u662fFDA\u6279\u51c6\u7684\u9996\u6b3e\u9776\u5411\u91dd\u5c0d\u8a72\u75c5\u539f\u9ad4\u7684\u7642\u6cd5\u3002 \u95dc\u65bc\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09 \u975c\u8108\u8f38\u6ce8\u578b\u7d44\u5408\u85e5\u7269\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7531Entasis Therapeutics\uff08Innoviva Specialty Therapeutics\u7684\u4e00\u5bb6\u95dc\u806f\u516c\u53f8\uff09\u958b\u767c\uff0c\u662f\u7531\u8212\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u985e\u6297\u751f\u7d20\uff09\u548c\u5ea6\u6d1b\u5df4\u5766\u9209\uff08\u4e00\u7a2e\u03b2-\u5167\u9170\u80fa\u9176\u6291\u5236\u5291\uff09\u7d44\u5408\u800c\u6210\u3002\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u5df2\u5728\u7f8e\u570b\u548c\u4e2d\u570b\u5167\u5730\u7372\u6279\uff0c\u7528\u65bc\u6cbb\u7642\u7531\u9b91\u66fc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\u654f\u611f\u5206\u96e2\u682a\u5f15\u8d77\u768418\u6b72\u53ca\u4ee5\u4e0a\u60a3\u8005\u7684\u91ab\u9662\u7372\u5f97\u6027\u7d30\u83cc\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u7d30\u83cc\u6027\u80ba\u708e\uff08HABP\/VABP\uff09\u3002\u518d\u9f0e\u91ab\u85e5\u64c1\u6709\u5728\u5927\u4e2d\u83ef\u5340\uff08\u4e2d\u570b\u5167\u5730\u3001\u9999\u6e2f\u3001\u53f0\u7063\u5730\u5340\u548c\u6fb3\u9580\u7684\u5408\u7a31\uff09\u3001\u97d3\u570b\u3001\u8d8a\u5357\u3001\u6cf0\u570b\u3001\u67ec\u57d4\u5be8\u3001\u8001\u64be\u3001\u99ac\u4f86\u897f\u4e9e\u3001\u5370\u5ea6\u5c3c\u897f\u4e9e\u3001\u83f2\u5f8b\u8cd3\u3001\u65b0\u52a0\u5761\u3001\u6fb3\u5927\u5229\u4e9e\u3001\u65b0\u897f\u862d\u548c\u65e5\u672c\u958b\u767c\u548c\u5546\u696d\u5316\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\u7684\u7368\u4f54\u8a31\u53ef\u3002 \u95dc\u65bc\u4e0d\u52d5\u687f\u83cc \u9b91\u66fc\u4e0d\u52d5\u687f\u83cc-\u918b\u9178\u9223\u4e0d\u52d5\u687f\u83cc\u5fa9\u5408\u9ad4\uff08\u4e0d\u52d5\u687f\u83cc\uff09\u662f\u9769\u862d\u6c0f\u9670\u6027\u3001\u4eba\u985e\u6a5f\u6703\u6027\u611f\u67d3\u75c5\u539f\u9ad4\uff0c\u4e3b\u8981\u611f\u67d3\u91cd\u75c7\u60a3\u8005\uff0c\u901a\u5e38\u6703\u5c0e\u81f4\u56b4\u91cd\u7684\u80ba\u708e\u548c\u8840\u6d41\u611f\u67d3\u3002\u5b83\u5011\u9084\u53ef\u4ee5\u611f\u67d3\u5176\u4ed6\u8eab\u9ad4\u90e8\u4f4d\uff0c\u4f8b\u5982\u6ccc\u5c3f\u9053\u548c\u76ae\u819a\u3002\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u88ab\u8a8d\u70ba\u662f\u4e00\u7a2e\u5168\u7403\u6027\u7684\u516c\u5171\u885b\u751f\u5a01\u8105\uff0c\u90e8\u5206\u539f\u56e0\u662f\u5176\u80fd\u5920\u7372\u5f97\u591a\u91cd\u8010\u85e5\u6027\u3002\u4e0d\u52d5\u687f\u83cc\u5c0d\u9752\u9ef4\u7d20\u985e\u85e5\u7269\u5177\u6709\u8010\u85e5\u6027\uff0c\u4e26\u4e14\u9084\u7372\u5f97\u4e86\u5c0d\u5e7e\u4e4e\u6240\u6709\u7528\u65bc\u6cbb\u7642\u9769\u862d\u6c0f\u9670\u6027\u83cc\u7684\u6297\u751f\u7d20\u7684\u8010\u85e5\u57fa\u56e0\uff0c\u5305\u62ec\u6c1f\u594e\u8afe\u916e\u985e\u85e5\u7269\u3001\u6c28\u57fa\u7cd6\u7518\u985e\u85e5\u7269\u3001\u982d\u5b62\u83cc\u7d20\u985e\u85e5\u7269\u548c\u78b3\u9752\u9709\u70ef\u985e\u85e5\u7269\u3002 \u7f8e\u570b\u75be\u75c5\u63a7\u5236\u8207\u9810\u9632\u4e2d\u5fc3\uff08CDC\uff09\u5df2\u5c07\u78b3\u9752\u9709\u70ef\u985e\u8010\u85e5\u5fae\u751f\u7269\u5217\u70ba\u7dca\u8feb\u5a01\u8105\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u662f2019\u5e74\u8207\u8010\u85e5\u6027\u76f8\u95dc\u7684\u6b7b\u4ea1\u7684\u516d\u5927\u4e3b\u8981\u75c5\u539f\u9ad4\u4e4b\u4e00\u3002\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u88ab\u4e16\u754c\u885b\u751f\u7d44\u7e54\u5217\u70ba\u512a\u5148\u7684\u75c5\u539f\u9ad4\u3002 \u5728\u7f8e\u570b\uff0c\u6bcf\u5e74\u9810\u8a08\u7d04\u670940,000\u5230800,000\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d0440%\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc,\u3002\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0c\u6bcf\u5e74\u7d04\u6709100\u842c\u4f8b\u4e0d\u52d5\u687f\u83cc\u75c5\u4f8b\uff0c\u5176\u4e2d\u7d04\u4e09\u5206\u4e4b\u4e8c\u662f\u8010\u78b3\u9752\u9709\u70ef\u985e\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u3002\u5168\u7403\u6bcf\u5e74\u6709\u8d85\u904e300,000\u4f8b\u6b7b\u4ea1\u8207\u8010\u78b3\u9752\u9709\u70ef\u985e\u4e0d\u52d5\u687f\u83cc\u6709\u95dc\u3002 \u95dc\u65bc\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5728\u4e2d\u570b \u6839\u64daCARSS\uff08\u5168\u570b\u7d30\u83cc\u8010\u85e5\u76e3\u6e2c\u7db2\uff092022\u5e74\u5e74\u5ea6\u5831\u544a\uff0c\u4e2d\u570b\u5167\u5730\u7d04\u670930\u842c\u4f8b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u5831\u544a\u3002\u6839\u64da\u6700\u65b0\u7684CHINET\u5831\u544a\uff0c\u4e2d\u570b\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u5c0d\u78b3\u9752\u9709\u70ef\u985e\u6297\u751f\u7d20\u7684\u8010\u85e5\u7387\u5df2\u5347\u81f3\u7d0474%\u3002\u5728\u4e2d\u570b\uff0c\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc\u4e5f\u662f\u5c0e\u81f4\u91ab\u9662\u7372\u5f97\u6027\u80ba\u708e\u548c\u547c\u5438\u6a5f\u76f8\u95dc\u6027\u80ba\u708e\u7684\u5e38\u898b\u75c5\u539f\u9ad4\u3002\u5728\u63d0\u4f9b\u73fe\u6709\u6cbb\u7642\u7684\u60c5\u6cc1\u4e0b\uff0c\u5176\u5728\u4e2d\u570b\u548c\u6771\u4e9e\u7684\u6b7b\u4ea1\u7387\u5206\u5225\u7d04\u70ba38%\u548c43%\u3002 Tala, B., Jad, A., Claude, A., Jihad, I., Chantal, L., Rakan, N.,&amp; Eid, A. (2017). Risk Factors, Clinical Presentation, and Outcome of\u202fAcinetobacter Centers for Disease Control and Prevention, \"Carbapenem-resistant\u202fAcinetobacter baumannii\u202f(CRAB): An urgent public health threat in\u202fUnited States\u202fhealthcare facilities,\"\u202fAugust 2021:\u202fhttps:\/\/arpsp.cdc.gov\/story\/cra-urgent-public-health-threat Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext World Health Organization, \"WHO publishes list of bacteria for which new antibiotics are urgently needed,\" February 27, 2017: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed Spellberg B, Rex JH. The value of single-pathogen antibacterial agents. Nat Rev Drug Discov. 2013 Dec;12(12):963. doi: 10.1038\/nrd3957-c1. Epub 2013 Nov 15. Centers for Disease Control and Prevention. Antibiotic Resistance &amp; Patient Safety Portal. \"Carbapenem-resistant Acinetobacter,\" May 2023: https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/carbapenem-resistant-acinetobacter Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.\u202fLancet. 2022; 399(10325):629-655. Supplementary Material. Supplementary appendix.\u202fhttps:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext China Diagnosis and Treatment Guideline for hospital-acquired pneumonia and ventilator-associated pneumonia, 2018;\u00a0 Chung DR, et al; Asian Network for Surveillance of Resistant Pathogens Study Group. Am J Respir Crit Care Med 2011; Du, et al. American Journal of Infection Control 00 (2019). \u00a0","breadcrumb":{"@id":"https:\/\/pingtungtimes.com.tw\/?p=237997#breadcrumb"},"inLanguage":"zh-TW","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pingtungtimes.com.tw\/?p=237997"]}]},{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/?p=237997#primaryimage","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":"3000","height":"1990"},{"@type":"BreadcrumbList","@id":"https:\/\/pingtungtimes.com.tw\/?p=237997#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9801","item":"https:\/\/pingtungtimes.com.tw\/"},{"@type":"ListItem","position":2,"name":"\u9f0e\u512a\u6a02\u00ae\uff08\u8212\u5df4\u5766\u9209-\u5ea6\u6d1b\u5df4\u5766\u9209\uff09\u7372\u4e2d\u570b\u570b\u5bb6\u85e5\u76e3\u5c40\u6279\u51c6\u4e0a\u5e02"}]},{"@type":"WebSite","@id":"https:\/\/pingtungtimes.com.tw\/#website","url":"https:\/\/pingtungtimes.com.tw\/","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","description":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831PingtungTimes\uff0c\u6700\u95dc\u5fc3\u5728\u5730\u7684\u5a92\u9ad4","publisher":{"@id":"https:\/\/pingtungtimes.com.tw\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pingtungtimes.com.tw\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-TW"},{"@type":"Organization","@id":"https:\/\/pingtungtimes.com.tw\/#organization","name":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831","url":"https:\/\/pingtungtimes.com.tw\/","logo":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/","url":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","contentUrl":"https:\/\/pingtungtimes.com.tw\/wp-content\/uploads\/2023\/02\/logo-150.png","width":150,"height":150,"caption":"\u5c4f\u6771\u6642\u5831\u96fb\u5b50\u5831"},"image":{"@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pingtungnews"]},{"@type":"Person","@id":"https:\/\/pingtungtimes.com.tw\/#\/schema\/person\/683b937f29ec1537972f6c41e22a2cf3","name":"\u7f8e\u901a\u793e","image":{"@type":"ImageObject","inLanguage":"zh-TW","@id":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6c21e24ce33ca5d4572e343395adac2bbef44ff7035a74ea2cab2443c7f0a5f3?s=96&d=blank&r=g","caption":"\u7f8e\u901a\u793e"},"url":"https:\/\/pingtungtimes.com.tw\/?author=16"}]}},"_links":{"self":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/237997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=237997"}],"version-history":[{"count":0,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/237997\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=\/wp\/v2\/media\/199219"}],"wp:attachment":[{"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=237997"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=237997"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pingtungtimes.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=237997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}